23 October 2024
B.P. Marsh & Partners Plc
("B.P.
Marsh", "the Company" or "the Group")
Half Year Results
B.P. Marsh & Partners Plc
(AIM: BPM), the specialist investor in early stage financial
services businesses, announces its unaudited Group Half Year
Results for the six months to 31 July 2024 (the
"Period").
Highlights:
· Total Shareholder return of 12.1% for the Period comprising
the growth in Net Asset Value and the aggregate dividends paid in
March, May and July 2024
· Net Asset Value has increased by £23.7m over the Period to
£252.9m, a 10.3% increase (31 January 2024: £229.2m; 31 July 2023:
£203.5m)
· Net Asset Value per share 690.8p*, a 9.8% increase (31
January 2024: 629.0p; 31 July 2023: 567.3p)
· Consolidated profit before tax of £29.0m for the Period (six
months to 31 July 2023: £15.6m; year ending 31 January 2024:
£43.6m)
· Group liquidity of £80.2m as at 31 July 2024
· Two Post Period new investments, both Underwriting Agencies,
in CEE Specialty and Volt UW
· Current liquidity £78.4m
*The fully diluted Net Asset Value
per share is 658.5p and includes the remaining 1,038,699 shares
held within the Employee Benefit Trust, but also includes £2.9m of
loan repayable if the remaining shares, including 236,259 currently
unallocated, are sold. The diluted NAV per share also includes the
1,682,500 options over ordinary shares granted to certain Directors
and employees of the Group in November 2023 as the performance
criteria for NAV growth had been met as at 31 July 2024 (31 January
2024: 626.9p; 31 July 2023: 556.3p).
Commenting on the results, Brian Marsh OBE, Chairman,
said:
"We are pleased to report another strong set of results,
delivering growth in portfolio value, investment realisations and
shareholder returns.
"The completion of the disposal of Paladin during the period
showcases the success of B.P. Marsh's investment model, our ability
to identify opportunities and to back successful management
teams.
"We remain committed to maintaining this momentum, leveraging
our expertise to drive further sustainable growth via new
investment opportunities and follow-on funding.
"The Board is pleased to welcome Fran as CFO, and given her
extensive experience and long-standing tenure, we believe she is
well-suited to assume the role. We would also like to thank Jon for
his service and wish him well for his future
endeavours."
Analyst briefing and investor
presentation:
An analyst presentation, hosted by
the Company, will be held on Wednesday 23 October 2024 at 10.00
a.m. BST. Analysts wishing to attend should contact
bpm@tavistock.co.uk
to register.
Management will also provide a
live presentation for all existing and potential shareholders via
the Investor Meet Company platform at 11.00 a.m. on 23 October
2024.
Questions can be submitted
pre-event via your Investor Meet Company dashboard up until 9.00
a.m. today or at any time during the live presentation.
Investors can sign up to Investor
Meet Company for free and add to meet B.P. Marsh via:
https://www.investormeetcompany.com/bp-marsh-partners-plc/register-investor
Note
This announcement contains inside
information for the purposes of Article 7 of Regulation (EU) No
596/2014.
For further information, please
visit www.bpmarsh.co.uk
or contact:
|
B.P. Marsh & Partners Plc
Brian Marsh OBE / Alice
Foulk
|
+44 (0)20 7233 3112
|
Nominated Adviser & Joint Corporate
Broker:
Panmure Liberum Limited
Atholl Tweedie / Amrit Mahbubani /
Ailsa MacMaster
|
+44 (0)20 7886 2500
|
Joint Corporate Broker:
Singer Capital Markets Advisory LLP
Charles Leigh-Pemberton / James
Moat / Asha Chotai
|
+44 (0)20 7496 3000
|
Financial PR & Investor Relations:
Tavistock
Simon Hudson / Katie
Hopkins
|
bpmarsh@tavistock.co.uk
+44 (0)20 7920 3150
|
Notes to Editors:
B.P. Marsh's current portfolio
contains seventeen companies. More detailed descriptions of the
portfolio can be found at www.bpmarsh.co.uk.
Since formation over 30 years ago,
the Company has assembled a management team with considerable
experience both in the financial services sector and in managing
private equity investments. Many of the directors have worked with
each other in previous roles, and all have worked with each other
for over ten years.
Statement by the Chairman and Managing
Director
We are pleased to present the
unaudited Consolidated Financial Statements of B.P. Marsh &
Partners Plc for the Period to 31 July 2024.
Half Year Results
During the Period the Group's Net
Asset Value ("NAV") has grown by £23.7m from £229.2m (31 January
2024) to £252.9m which together with the aggregate dividends paid
in March 2024, May 2024 and July 2024 represents a Total
Shareholder Return of 12.1%. This equals an NAV per share of 658.5p
on a fully diluted basis following the vesting of the shares in the
Group's Joint Share Ownership Plan and inclusion of the options
over the Company's shares granted under the Group's Share Option
Plan in November 2023 following achievement of the NAV growth
criteria; an increase of 5.0% from 31 January 2024.
As previously announced, during
the Period, the Group completed a new investment in Devonshire UW
Limited, a transactional risk Underwriting Agency. The Group also
made a further investment into Pantheon Specialty Group Limited,
acquiring a further 7% from Management, bringing its shareholding
up to 32%. The Company also participated in a pre-emption process
at XPT Group LLC, whereby it acquired US $1.0m worth of shares as
part of a wider internal share issue.
Post Period end the Group has made
two further new investments. These were also in Underwriting
Agencies; one based in the Czech Republic, CEE Specialty s.r.o, and
the other is a newly established energy Underwriting Agency, Volt
UW Ltd. The Board was impressed with the track record and strategic
positioning displayed by the respective management teams and is
looking forward to partnering with these strong management teams
and assisting them to achieve their growth ambitions.
During the Period, the Company
distributed the first year of its intended three year aggregate
£12m dividend distribution programme with a total of 10.72p per
share (£4.0m in total) distributed in the Period. The Company has
distributed 49.17p per share to its shareholders since its
flotation, equivalent to 8.7% of the share price at the date of
writing (567.5p).
The Board continues to aspire to
pay at least a further £4m in the year to 31 January 2026 and in
the year to 31 January 2027.
The Company initiated a new Share
Buy-back programme in June 2024, permitting purchases up to a 15%
discount to Net Asset Value, with a £1m budget allocation. During
the Period 13 Share buy-back trades were conducted, purchasing an
aggregate 63,132 shares for a quantum of £326,379, at an
average of 517p per share. Post Period end, the maximum purchase
price was increased, and the discount to Net Asset Value threshold
was lowered to 10%, and a further 93,570 Shares have been
bought-back, with £164,733 of the original £1m budget remaining.
The Board considers that the buy-back programme has been
successful, allowing the Company to purchase small yet consistent
parcels of Shares where available in a NAV accretive way within the
restrictions set by the Market Abuse (Amendment) (EU Exit)
Regulations 2019.
As we progress through the
remainder of 2024, the Group is well-positioned in terms of cash
reserves and new business opportunities, enabling us to capitalise
on prospects both within and beyond our current portfolio in line
with the methodology that has delivered strong historic results. We
aim to meet the capital needs of our portfolio to support further
growth while ensuring we remain ready to invest in any promising
new business opportunities that meet our criteria. The Group will
carefully evaluate each investment approach to ensure that capital
is invested and protected appropriately. We are encouraged by the
breadth of the current pipeline of new business
opportunities.
The Board welcomed Francesca
Chappell as Chief Finance Officer in September 2024, following the
departure of Jonathan Newman. Ms. Chappell has been with the
Company since 2013, with a wealth of experience in all areas of the
business, and has been able to seamlessly transition into this
role. The Company has always prioritised investment and further
training within its staff base at all levels and the inherent
succession planning that this can accommodate we feel will benefit
all stakeholders.
The Group remains fully cognisant
of the ongoing challenges posed by the broader economic climate.
While there are positive indicators, such as inflation stabilising
and interest rates potentially nearing their peak, these challenges
are not yet fully resolved. The Group continues to monitor these
developments closely, recognising that the economic landscape
remains uncertain. The Group has consistently monitored the effects
of the rising cost of living on its employees and has taken action
where deemed necessary. Due to the Group's debt-free status and its
dual investment strategy, which includes both equity and loan
funding benchmarked against the base rate, we have successfully
mitigated the negative impact of rising interest rates.
The Group is pleased with its
performance as of July 31 2024, which reaffirms the strength of its
track record.
Brian Marsh
|
Alice Foulk
|
Chairman
|
Managing Director
|
23 October 2024
|
23 October 2024
|
Chief Investment Officer Update
In the six month period to 31 July
2024 the underlying portfolio performed well, continuing on from
the Group's strongest set of full year results to 31 January
2024.
Over the Period, the valuation of
the Group's equity portfolio has increased by 24% adjusting for
additions and disposals, with NAV increasing by 10.3%.
Over the past 12 months, the
equity portfolio has increased by 61.8% adjusting for additions and
disposals, with NAV increasing by 24.3%.
The Group's
current cash balance is £78.4m and will allow the Group to continue
to do what it does best:-
· Identify enterprises with robust management teams and
significant growth potential;
· Provide funding, support, and development resources to these
companies, enabling them to capitalise on growth opportunities;
and
· Generate returns on investments made for our shareholders
through a combination of ongoing equity growth within the portfolio
and regular shareholder distributions.
In line with previous disposals,
the Group is committed to reinvesting its cash balances into both
its existing portfolio and new ventures, while also ensuring an
appropriate return to shareholders through our announced dividends
and Share Buy-back policies.
The Group continues to focus on
identifying new business opportunities and has an active pipeline
of prospects currently under consideration. This has been shown by
the three investments completed by the Group both within the Period
and post.
During the Period, the Group
completed one new investment, being Devonshire UW Limited, a
London-based Underwriting Agency, specialising in transactional
risks encompassing Warranty & Indemnity, Specific Tax, and
Legal Contingency Insurance.
Post Period end, the Group
completed two new investments, as follows:-
· CEE Specialty s.r.o - an underwriting
agency based in Prague, Czech Republic with a branch office in
Bucharest, Romania, which specialises in Marine Hull, Bonds and
Liability insurance, targeting business in Central and Eastern
Europe.
· Volt UW Holdco Limited - a
London-based Underwriting Agency, which specialises in energy
insurance with a clear focus on insuring property risks associated
with power generation and midstream energy, in both the
non-renewable and renewable sector.
The Group remains dedicated to
uncovering new business opportunities and has an active pipeline of
prospects currently in evaluation. With this robust pipeline, the
Group anticipates making additional investments by the end of its
financial year on 31 January 2025.
B.P. Marsh is highly regarded
within the financial services (sub)sector in which it specialises,
particularly concerning Insurance Brokers and Underwriting
Agencies.
The Group continues to commit to
investing in niche SME sectors, backed by skilled and knowledgeable
management teams, which promotes long-term growth and generates
significant value.
Given the strength of the Group's
cash position and its market reputation, we believe the business is
well-equipped to seize opportunities within our current portfolio,
as well as explore new prospects in the financial services sector,
particularly in the insurance market.
The Group is actively tracking
emerging trends in the insurance sector, with a focus on premium
rates and mergers and acquisitions (M&A).
The latest trends in rate changes
show that across the global insurance market, rates were flat in
the second quarter of 2024. This is the first time since the third
quarter of 2017 that global insurance has not increased. This also
represents a decrease from the peak rate of 22% observed in the
fourth quarter of 2020.
Rate increases were less consistent
across all lines and regions in which our portfolio operates. Rates
are still increasing across specific product lines and in regions
across the world.
Global Casualty rates increased by
3% in the second quarter of 2024, which was the same increase as in
the first quarter of 2024. Global Property rates were flat in in
the second quarter of 2024, down from a 3% increase in the first
quarter of 2024.
Global Financial and Professional
lines, alongside Cyber, were the main driver of overall rate
increasing slowing down, falling by 5% and 6% in the second quarter
of 2024 respectively.
Rate increases continue to slow as
overall market capacity has increased, via new market entrants and
existing carriers increasing their exposure.
Overall, the Group does not
anticipate a return to the pricing levels seen during the last soft
market in the short term. Given the
portfolio predominantly operates in specialist risk areas, rates
tend to be less volatile and therefore we remain confident that our
portfolio is suitably prepared to weather a softening
market.
Regarding the insurance M&A
market, the ongoing consolidation trends in the Insurance Market
show no indication of abating in 2024. This activity remains a
catalyst for substantial prospects for the Group, both in terms of
new investments and activity within our core portfolio.
Portfolio Update
New
Investments
During the Period to 31 July 2024,
the Group completed one new acquisition:-
Devonshire UW Limited
("Devonshire")
- N/A pence NAV per share
change in the Period
In March 2024, the Group completed
the investment in Devonshire, the London-based underwriting agency
specialising in transactional risks, including Warranty &
Indemnity, Specific Tax, and Legal Contingency
Insurance.
The business has been founded by
four experienced industry practitioners, Natasha Attray, James
Dodd, James Fletcher and Charles Turnham, who have a collective 30
years of transactional liability underwriting
experience.
Devonshire is backed by Lloyd's
capacity with support from a strong panel of A-rated insurance
capacity providers. The business will provide risk solutions for
large M&A transactions for brokers, corporates, private equity
firms, professional advisers and other specialist
investors.
Date of initial investment: March
2024
31 July 2024
valuation: £300,000
Cost of Equity:
£300,000
Equity stake: 30.00%
Post Period end, the Group
completed on two further acquisitions:-
CEE Specialty s.r.o ("CEE
Specialty")
- N/A pence NAV per share
change in the Period
In September 2024, B.P. Marsh
acquired a 44% shareholding in CEE Specialty, an underwriting
agency based in Prague, Czech Republic with a branch office in
Bucharest, Romania.
CEE Specialty was founded in 2019
and specialises in Marine Hull, Bonds and Liability Insurance,
targeting businesses in Central and Eastern Europe.
The business is led by James
Grindley (CEO) and Tomáš Maršálek (CFO), with CEE Specialty being
previously majority owned by CEE Specialty Holdings S.A., a
subsidiary of Royalton Capital Investors II L.P., an alternative
investment fund manager.
James Grindley has 28 years of
experience in various executive management positions within the
re/insurance industry, including Lloyd's and the Central and
Eastern European markets.
Tomáš Maršálek has 19 years of
experience in fund management and venture capital. This has
included various senior executive management positions at SMEs
(including start-ups), mainly as Chief Financial
Officer.
With a team of 15 insurance
professionals, CEE Specialty provided B.P. Marsh with an excellent
opportunity to invest in a business with a well-established and
highly experienced leadership team and strong growth potential over
the coming years.
The Company provided €3.3m of
funding to complete this transaction, which was utilised in full
upon completion as part of a management buy-out, with management
now owning 56% of CEE Specialty.
Date of initial investment:
September 2024
31 July 2024
valuation: N/A
Cost of Equity:
€2,819,852 (£2,354,134)
Equity stake: 44.00%
Volt UW Holdco Limited
("Volt")
- N/A pence NAV per share
change in the Period
In October 2024, the Group
announced that it had subscribed for a 25.5% Cumulative Preferred
Ordinary shareholding in Volt, a London-based Underwriting Agency.
B.P. Marsh provided funding of up to £2.5m via both equity and a
loan facility, which will be partially drawn down upon
completion.
Volt specialises in energy
insurance, focusing specifically on insuring property risks related
to power generation and midstream energy across both non-renewable
and renewable sectors. The agency was established by three seasoned
industry professionals: Chris Allison, Andrew Tokley, and Kevin
Cleary.
With the backing of B.P. Marsh,
management aims to develop a best-in-class, client-centric energy
underwriting agency with a strong emphasis on Environmental,
Social, and Governance (ESG) principles. The company will be
headquartered in London and will underwrite a global portfolio of
energy-related business, with a particular emphasis on the United
States.
Volt operates as a Lloyd's
Coverholder and has secured A-rated capacity from both Lloyd's and
non-Lloyd's carriers, with long-term profitability and
sustainability for insurers and reinsurers being integral to Volt's
business strategy.
The Co-founders, Chris Allison,
Andrew Tokley and Kevin Cleary each have over 25 years' experience
working in senior leadership positions at various underwriting-led
businesses; including large (re)insurance companies, Lloyd's
syndicates and underwriting agencies, each having a proven track
record of success.
The Group looks forward to
continuing its support for Volt and its management team in the
years ahead, assisting the business in achieving its long-term
aspirations and objectives.
Date of initial investment:
October 2024
31 July 2024
valuation: N/A
Cost of Equity: £25.50
Equity stake: 25.50%
Follow-on Investments and Funding
XPT Group LLC
("XPT")
+ 15.5 pence NAV per
share uplift in Period
The Group's investment in XPT, the
specialty lines insurance distribution company, continues to
perform well, with the business on track to produce Gross Written
Premium of close to US $900m in its financial year to 31 December
2024 (31 December 2023: US $675m).
XPT's exceptional growth has been
driven by various factors, both via its acquisition strategy,
individual and team hires and underlying organic growth. This has
included strong performance from XPT's property and casualty
divisions and successful new producer hires in the Platinum
Construction business.
XPT continues to look at new
acquisitions and further announcements on this should be made
before the year end.
XPT has made 16 business
acquisitions since the Group first invested in 2017. XPT now has
offices in 20 locations across 13 States,
acting for insureds across all of the USA.
XPT's performance since its
inception has been impressive and its continued acquisition
strategy, alongside strong organic growth means that XPT is well
positioned to continue this growth into 2025.
In the Period, the Group provided
XPT with a further US $1m of funding (c. £0.8m) as part of
pre-emption offering.
Date of investment: June
2017
31 July 2024 valuation:
£48,788,000
Cost of
Equity: £13,842,158
Equity stake: 27.49%
Pantheon Specialty Limited
("Pantheon")
+ 27.3 pence NAV per
share uplift in the Period
The Group first invested in
Pantheon in June 2023, when it subscribed for a 25% stake in a new
holding company established in partnership with Robert
Dowman.
Robert has over 30 years'
experience in the market and is seen by the industry as a
leading London Market Casualty broker, specialising in the larger
more complex liability placements across the world, whether that be
on a facultative or programme basis.
Within the Period, the
Group acquired from Pantheon's founders a
further 7% shareholding in Pantheon for an upfront consideration
paid of £7.3m, increasing the Group's equity stake to
32%.
Since Pantheon was established,
just over one year ago, Mr Dowman has hired a number of key
individuals, and has built a market leading independent specialist
broker with the Pantheon team recognised as leading London Market
Casualty brokers, specialising in complex liability placements
worldwide.
Since investment, Pantheon has
performed strongly, and in its current financial year to 31
December 2024, Pantheon is forecast to produce an adjusted EBITDA
in excess of £16m. This growth has been demonstrated in Pantheon's
notable increase in valuation to £32.6m as at 31 July
2024.
Pantheon is well positioned to
continue this impressive growth into 2025 and beyond.
Date of initial investment: June
2023
31 July 2024
valuation: £32,694,000
Cost of Equity:
£7,300,025
Equity stake: 32.00%
NAV breakdown by portfolio
company
The composition of B.P. Marsh's
underlying investment portfolio can be found here:
The Group's current active
investments are in the Insurance Intermediary sector.
These insurance investments are
budgeting to produce in the aggregate £1.34bn of insurance premium
during 2024, and a breakdown between brokers and MGAs can be found
here:-
Insurance Brokers
Investments:
The Group's Broking investments
are budgeting to place over £739m of GWP, producing
over £69m of commission income in 2023, accessing
specialty markets around the world.
Underwriting Agencies / Managing General Agents
("MGAs")
Investments:
The Group's MGAs are budgeting to
place almost £605m of GWP, producing
over £71m of commission income in 2024, across over 30
product areas, on behalf of more than 50 insurers.
Holding Company for exited
investment with Deferred Consideration
LEBC Holdings Limited
("LEBC")
- 2.4 pence NAV per share
change in the Period
In the Period, the previously
announced transaction whereby LEBC sold its wholly owned subsidiary
Aspira Corporate Solutions Limited to Titan Wealth Holdings
Limited, completed on 16 April 2024.
The transaction allowed LEBC to
meet all its obligations as agreed with the Financial Conduct
Authority regarding historical defined benefit pension transfer
advice.
Further proceeds of the sale will
be received over a three year earn-out period. As at our last set
of results, due to the number of variables involved, the Group have
taken a conservative approach to potential proceeds, which has been
factored into its valuation of LEBC as at 31 July 2024.
Date of initial investment: April
2007
31 July 2024
valuation: £4,156,000
Cost of
Equity: £13,473,657
Equity stake: 61.86%
Portfolio Company Highlights:
ATC Insurance Solutions PTY
Limited ("ATC")
+ 13.6 pence NAV per
share change in the Period
ATC continues to perform strongly
across its many product offerings in accident & health, motor
and sports insurance, amongst others.
For the financial year ending 30
June 2024, ATC achieved substantial year-on-year growth in Gross
Written Premium, Revenue, and EBITDA.
Specifically, ATC generated EBITDA
approaching AU $15m, marking an increase of over 40% compared to
the previous financial year.
Looking ahead, ATC are looking to
increase GWP by over 20% to over AU $225m in their current
financial year to June 2025, which demonstrates ATC's continued
ambition to continue their impressive growth record to date.
Date of initial investment: July
2018
31 July 2024
valuation: £23,566,000
Cost of
Equity: £6,476,595
Equity stake: 25.39%
Lilley Plummer Risks Limited
("LPR")
+ 9.5 pence NAV per share
change in the Period
Lilley Plummer Risks (LPR) has
continued to deliver outstanding performance, driven by growth in
its core marine insurance portfolio and expansion into additional
sectors.
The company has made strategic
hires to support its entry into new business lines, reflecting a
long-term goal of evolving into a multi-line specialist insurance
broker. LPR is actively exploring the market for team acquisitions
to accelerate this growth.
In terms of financial
expectations, the company forecasts an EBITDA of no less than £5m
for its financial year ending December 2024 as previously
announced.
Date of initial investment:
October 2019
31 July 2024 valuation:
£17,132,000
Cost of Equity:
£308,242
Equity stake: 28.43%
Stewart Specialty Risk
Underwriting Ltd ("SSRU")
0 pence NAV per share change
in the Period
SSRU continues to deliver
specialist insurance products to a wide array of clients in the
Construction, Manufacturing, Onshore Energy, Public Entity and
Transportation sectors.
In SSRU's year to 31 December
2023, Gross Written Premium exceeded CA $75m, with the budget of
approaching CA $100m for 2024, with further growth expected into
2025.
If SSRU achieves its 2024 budget,
EBITDA would have over doubled since 2020, from c. CA $3.5m to CA
$9.2m, with further growth expected into 2025.
During the Period, SSRU entered
into two new carrier partnerships. These new strategic alliances
not only expand SSRU's capacity but also reinforce its commitment
to offering innovative solutions to their broker partners and
insureds.
These new carrier partnerships
will allow SSRU to continue on its journey of organic growth of its
existing, highly profitable business lines.
Date of initial investment:
January 2017
31 July 2024
valuation: £11,870,000
Cost of
Equity: £19.00
Equity stake as at 31 July 2024:
28.41%
Dan Topping
Chief Investment Officer
23 October 2024
Chief Finance Officer Update
I am pleased to present my first
update as Group Chief Finance Officer.
The Group had another strong
period, delivering an increase in NAV of £23.7m (10.3%) to £252.9m,
compared with an increase of £13.9m (7.3%) in the same period in
2023. Including the £4.0m aggregate dividend paid in March 2024,
May 2024 and July 2024, this represented an overall return of 12.1%
for the Period.
Over the year to 31 July 2024 the
NAV has increased by £49.4m (24.3%). Including the £5.0m aggregate
dividend paid in November 2023, March 2024, May 2024 and July 2024,
this represents an overall return of 26.7%.
The NAV of £252.9m at 31 July 2024
represents a total increase in NAV of £223.7m since the Group was
originally formed in 1990 having adjusted for the original capital
investment of £2.5m, the £10.1m net proceeds raised on AIM in 2006
and the £16.6m net proceeds raised through the Share Placing and
Open Offer in July 2018. The Directors note that the Group has
delivered an annual compound growth rate of 9.7% in Group NAV after
running costs, realisations, losses, distributions and corporation
tax since flotation and 12.2% since 1990.
The equity investment portfolio
continued to increase in value, rising by 24.0% to £153.4m (31
January 2024: £165.4m) after adjusting for £42.1m of net
realisations and £9.5m of acquisitions in the Period, and after
adjusting for a £9.0m reclassification of deferred consideration
relating to the disposal of Paladin from the equity investment
portfolio to a debtor within the Consolidated Statement of
Financial Position.
The Group made one realisation
during the Period totalling £42.1m, being the sale of the Group's
entire 38.63% investment in Paladin which completed on 22 March
2024.
The Group invested a total of
£9.5m in equity in the portfolio during the Period (6 months to 31
July 2023: £0.4m):-
· £9.2m into the existing portfolio, including £7.3m in
Pantheon, £1.1m in LEBC and £0.8m in XPT; and
· £0.3m into one new investment, Devonshire.
Operating income
Net gains from investments were
£28.3m for the Period, of which £28.1m related to unrealised gains
on the revaluation of the investment portfolio, compared to £14.8m
of net gains for the 6 months to 31 July 2023, a 91.2%
increase.
Despite the Group making two
significant realisations in the 12 month period to 31 July 2024,
income from the portfolio for the Period increased from £4.0m in H1
2023 to £4.2m in H1 2024. Dividend income was £0.1m higher due to
strong investment portfolio performance, whilst loan interest
increased by £0.3m as a result of new loans granted and higher
interest rates charged due to Bank of England base rate increases.
Fee income decreased by £0.1m due to there being a higher amount of
one-off transaction and loan arrangement fees charged in H1 2023
compared to H1 2024 as well as a general reduction in fees charged
due to the realisations made over the 12 months to 31 July
2024.
Operating expenses
A significant proportion of the
increase in operating expenses to £4.9m in the Period from £2.8m in
H1 2023 related to increased staff costs of £1.9m in line with the
Company's financial performance and realisations made, which
resulted in one-off bonuses being awarded to staff. The remaining
£0.2m increase related to general cost inflation and expenses
relating to the implementation of the Group's Share Option
Scheme.
Profit on ordinary
activities
The consolidated profit on
ordinary activities before taxation for the Period was £29.0m which
represented an increase of 86% over the £15.6m reported in the same
period in 2023. The consolidated profit on ordinary activities
after tax was £26.6m, representing an increase of 71% over the
£15.5m reported in H1 2023.
The Group's strategy is to cover
expenses from the portfolio yield. On an underlying basis,
including treasury returns and realised gains, but excluding
unrealised investment activity (unrealised gains on equity
revaluation and provision against loans receivable from investee
companies), this was achieved with a pre-tax profit of £0.9m for
the Period (H1 2023: £0.8m).
Liquidity and loan
portfolio
In addition to contributing equity
to its investment portfolio, the Group frequently extends loan
financing, either as part of the initial investment structure or as
subsequent funding to support further growth. This additional
financing may be used for acquisitions, working capital,
recruitment, or product development.
The loan portfolio decreased by
£9.7m during the Period to £19.2m at 31 July 2024 (31 January 2024:
£28.9m, 31 July 2023: £17.8m).
The Group provided £1.4m in new loans - £0.4m to
Ai Marine and £1.0m to Devonshire. The Group received £11.0m in
loan repayments - £5.9m from Paladin, £3.3m from LEBC, £1.5m from
Pantheon and £0.3m from Fiducia. In addition there was a £0.1m
reduction due to foreign exchange movements and loan
impairments.
Since 31 July 2024 the Group has
provided £2.2m in further loans, including £1.6m in respect of its
new investments in Volt (£1.2m) and CEE Specialty (£0.4m) and £0.6m
to its existing portfolio in respect of further drawdowns from
agreed loan facilities, with £0.3m provided to Devonshire, £0.2m to
Ai Marine and £0.1m to Verve. The Group also received £1.1m in loan
repayments, including £1.0m from Pantheon and £0.1m from Fiducia.
The loan portfolio balance is currently £20.2m.
At 31 July 2024 the Group had
total available cash and treasury funds of £80.2m (31 January 2024:
£40.5m, 31 July 2023: £4.3m).
Between 31 January 2024 and 31
July 2024 the Group paid dividends totalling £4.0m and bought back
£0.3m in shares.
The Group is debt free.
Undiluted / diluted NAV per
share
The NAV per share at 31 July 2024
is 690.8p (31 January 2024: 629.0p and 31 July 2023:
567.3p). Previously, 1,461,302 shares being held within an
Employee Benefit Trust as part of a long-term share incentive plan
for certain directors and employees of the Group were excluded as
they did not carry voting or dividend rights. However, in October
2023, voting and dividend rights were granted for the 1,206,888
allocated shares which resulted in them being included in the
undiluted NAV per share calculation. During the Period 404,448 of
these allocated shares were sold, leaving 802,440 allocated shares
within the Employee Benefit Trust. During the period the Group
received £1.2m of loan debt owed by the Trust in relation to the
original transfer of shares which is reflected within the Group's
NAV of £252.9m as at 31 July 2024. The remaining 802,440 allocated
shares are included in the undiluted NAV per share calculation,
alongside £2.2m of loan debt, which remains repayable by the Trust
in relation to the original transfer of shares. This debt cannot
currently be consolidated within the accounts but will be repaid if
the shares are sold.
The diluted NAV per share as at 31
July 2024 is 658.5p (31 January 2024: 626.9p and 31 July 2023:
556.3p). This includes the full 1,038,699 shares remaining within
the Employee Benefit Trust and also includes £2.9m of loan
repayable if the shares, including the 236,259 shares that are
currently unallocated, were sold.
The diluted NAV per share
calculation also includes the 1,682,500 options over ordinary
shares granted to certain Directors and employees of the Group in
November 2023, which became dilutive as at 31 July 2024 as the
performance criteria for NAV growth had been met.
Francesca Chappell
Chief Finance Officer
23 October 2024
Investments
As at 31 July 2024 the Group's equity interests were as
follows:
Ag
Guard PTY Limited
(www.agguard.com.au)
Ag Guard is a Managing General
Agency, which provides insurance to the agricultural sector, based
in Sydney, Australia. The Group holds its investment through Ag
Guard's Parent Company, Agri Services Company PTY
Limited.
Date of investment: July 2019
Equity stake: 41.0%
31
July 2024 valuation: £1,818,000
Ai
Marine Risk Limited
(www.aimarinerisk.com)
Ai Marine is a start-up MGA with a
focus on marine hull insurance and with a strong focus on the UK
& Europe, Middle East and Asia Pacific regions.
Date of investment: December 2023
Equity stake: 30.0%
31
July 2024 valuation: £30,000
Asia Reinsurance Brokers (Pte) Limited
(www.arbrokers.asia)
ARB is an independent specialist
reinsurance and insurance risk solutions provider headquartered in
Singapore.
Date of investment: April 2016
Equity stake: 25.0%
31
July 2024 valuation: £1,734,000
ATC
Insurance Solutions PTY Limited
(www.atcis.com.au)
ATC is a Managing General Agency
and Lloyd's Coverholder, specialising in accident & health,
construction & engineering, trade pack, motor and sports
insurance headquartered in Melbourne, Australia.
Date of investment: July 2018
Equity stake: 25.4%
31
July 2024 valuation: £23,566,000
Criterion Underwriting (Pte) Limited
Criterion was established to
provide specialist insurance products to a variety of clients in
the cyber, financial lines and marine sectors in Far East Asia,
based in Singapore.
Date of investment: July 2018
Equity stake: 29.4%
31
July 2024 valuation: £0
Devonshire UW Limited
Devonshire is a London-based
Underwriting Agency specialising in transactional risks.
Date of investment: March 2024
Equity stake: 30.0%
31
July 2024 valuation: £300,000
The Fiducia MGA Company Limited
(www.fiduciamga.co.uk)
Fiducia is a UK marine cargo
Underwriting Agency and Lloyd's Coverholder which specialises in
the provision of insurance solutions across a number of marine
risks including, cargo, transit liability, engineering and
terrorism Insurance.
Date of investment: November 2016
Equity stake: 35.2%
31 July 2024
valuation:
£5,631,000
LEBC Holdings Limited
(www.lebc-group.com)
LEBC is an Independent Financial
Advisory company providing services to individuals, corporates and
partnerships, principally in employee benefits, investment and life
product areas.
Date of investment: April 2007
Equity stake: 61.9%
31 July 2024
valuation:
£4,156,000
Lilley Plummer Risks Limited
(www.lprisks.co.uk)
Lilley Plummer Risks is an
independent Lloyd's broker that provides a wide array of offerings
in several diverse and niche areas. The
Group holds its investment in Lilley Plummer Risks through its
holding company Lilley Plummer Holdings Limited.
Date of investment: October 2019
Equity stake: 28.4%
31 July 2024 valuation:
£17,132,000
Pantheon Specialty Group Limited
(www.pantheonspecialty.com)
Pantheon is a holding company
established in partnership with Robert Dowman. With the support of
B.P Marsh, Robert Dowman is looking to build a market leading
independent specialist broker, across multiple markets.
Date of investment: June 2023
Equity stake: 32.0%
31 July 2024 valuation:
£32,694,000
Sage Program Underwriters, Inc.
(www.sageuw.com)
Sage provides specialist insurance
products to niche industries, initially in
the inland delivery and field sport sectors based in Bend,
Oregon.
Date of Investment: June 2020
Equity Stake: 30.0%
31 July 2024 Valuation: £2,036,000
Sterling Insurance PTY Limited
(www.sterlinginsurance.com.au)
Sterling is a specialist Underwriting Agency offering a range of
insurance solutions within the Liability sector,
specialising in niche markets including mining,
construction and demolition based in Sydney Australia. The Group
holds its investment in Sterling via a joint venture with Besso
Insurance Group Limited, Neutral Bay Investments
Limited.
Date of investment: June 2013
Equity stake: 19.7%
31 July 2024 valuation:
£3,326,000
Stewart Specialty Risk Underwriting Ltd
(www.ssru.ca)
SSRU is a Managing General Agency,
providing insurance solutions to a wide array of clients in the
construction, manufacturing, onshore energy, public entity and
transportation sectors based in Toronto, Canada.
Date of investment: January 2017
Equity stake: 28.4%
31 July 2024 valuation:
£11,870,000
Verve Risk Services Limited
Verve is a London based Managing
General Agency specialising in Professional and Management
Liability for the insurance industry. Verve operates in the USA,
Canada, Bermuda, Cayman Islands and Barbados.
Date of investment: April 2023
Equity stake: 35.0%
31
July 2024 valuation: £365,000
XPT
Group LLC
(www.xptspecialty.com)
XPT is a wholesale insurance
broking and Underwriting Agency platform across the U.S. Specialty
Insurance Sector operating from many locations in the United States
of America.
Date of investment: June 2017
Equity stake: 27.5%
31
July 2024 valuation: £48,788,000
These investments have been valued
in accordance with the accounting policies on Investments set out
in note 1 of our Half Year Consolidated Financial
Statements.
Forward-looking
statements:
Certain statements in this
announcement are forward-looking statements. In some cases, these
forward looking statements can be identified by the use of forward
looking terminology including the terms "anticipate", "believe",
"intend", "estimate", "expect", "may", "will", "seek", "continue",
"aim", "target", "projected", "plan", "goal", "achieve" and words
of similar meaning or in each case, their negative, or other
variations or comparable terminology. Forward-looking statements
are based on current expectations and assumptions and are subject
to a number of known and unknown risks, uncertainties and other
important factors that could cause results or events to differ
materially from what is expressed or implied by those statements.
Many factors may cause actual results, performance or achievements
of B.P. Marsh to be materially different from any future results,
performance or achievements expressed or implied by the
forward-looking statements. Important factors that could cause
actual results, performance or achievements of B.P. Marsh to differ
materially from the expectations of B.P. Marsh, include, among
other things, general business and economic conditions globally,
industry trends, competition, changes in government and changes in
regulation and policy, changes in its business strategy, political
and economic uncertainty and other factors. As such, undue reliance
should not be placed on forward-looking statements. Any
forward-looking statement is based on information available to B.P.
Marsh as of the date of the statement. All written or oral
forward-looking statements attributable to B.P. Marsh are qualified
by this caution. Other than in accordance with legal and regulatory
obligations, B.P. Marsh undertakes no obligation to publicly update
or revise any forward-looking statement, whether as a result of new
information, future events or otherwise. Nothing in this
announcement should be regarded as a profit forecast.
Half Year Consolidated Financial Statements
CONSOLIDATED STATEMENT OF
COMPREHENSIVE INCOME
FOR THE PERIOD ENDED 31ST
JULY 2024
|
Notes
|
Unaudited
|
|
Unaudited
|
|
Audited
|
|
|
6 months
to
|
|
6 months
to
|
|
Year
to
|
|
|
31st July 2024
|
|
31st July 2023
|
|
31st January 2024
|
|
|
£'000
|
£'000
|
|
£'000
|
£'000
|
|
£'000
|
£'000
|
GAINS ON INVESTMENTS
|
|
|
|
|
|
|
|
|
|
Realised gains / (losses) on disposal
of equity investments (net of costs)
|
6
|
1,551
|
|
|
(41)
|
|
|
(37)
|
|
Net (provision) / release of
provision made against equity investments and loans
|
6
|
(1,369)
|
|
|
12
|
|
|
24
|
|
Unrealised gains on equity investment
revaluation
|
4
|
28,113
|
|
|
14,755
|
|
|
43,711
|
|
|
|
|
28,295
|
|
|
14,726
|
|
|
43,698
|
INCOME
|
|
|
|
|
|
|
|
|
|
Dividends
|
|
2,368
|
|
|
2,280
|
|
|
3,504
|
|
Income from loans and
receivables
|
|
1,123
|
|
|
815
|
|
|
1,861
|
|
Fees receivable
|
|
721
|
|
|
860
|
|
|
2,103
|
|
|
|
|
4,212
|
|
|
3,955
|
|
|
7,468
|
OPERATING INCOME
|
|
|
32,507
|
|
|
18,681
|
|
|
51,166
|
|
|
|
|
|
|
|
|
|
|
Operating expenses
|
|
|
(4,909)
|
|
|
(2,844)
|
|
|
(7,881)
|
|
|
|
|
|
|
|
|
|
|
OPERATING PROFIT
|
|
|
27,598
|
|
|
15,837
|
|
|
43,285
|
|
|
|
|
|
|
|
|
|
|
Financial income
|
|
1,566
|
|
|
95
|
|
|
721
|
|
Financial expenses
|
|
(86)
|
|
|
(25)
|
|
|
(55)
|
|
Exchange movements
|
|
(30)
|
|
|
(349)
|
|
|
(333)
|
|
|
|
|
1,450
|
|
|
(279)
|
|
|
333
|
PROFIT ON ORDINARY ACTIVITIES BEFORE TAXATION
|
|
|
29,048
|
|
|
15,558
|
|
|
43,618
|
|
|
|
|
|
|
|
|
|
|
Income taxes
|
|
|
(2,428)
|
|
|
(6)
|
|
|
(1,089)
|
|
|
|
|
|
|
|
|
|
|
PROFIT ON ORDINARY ACTIVITIES AFTER TAXATION ATTRIBUTABLE
TO EQUITY HOLDERS
|
7
|
|
£26,620
|
|
|
£15,552
|
|
|
£42,529
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL COMPREHENSIVE INCOME FOR THE PERIOD
|
7
|
|
£26,620
|
|
|
£15,552
|
|
|
£42,529
|
|
|
|
|
|
|
|
|
|
|
Earnings per share - basic
(pence)
|
3
|
|
72.0p
|
|
|
43.3p
|
|
|
114.7p
|
Earnings per share - diluted
(pence)
|
3
|
|
68.4p
|
|
|
41.6p
|
|
|
114.0p
|
|
|
|
|
|
|
|
The result for the period is
wholly attributable to continuing activities.
CONSOLIDATED STATEMENT OF
FINANCIAL POSITION
AS AT 31ST JULY
2024
(Company Number:
05674962)
|
|
Unaudited
|
|
Unaudited
|
|
Audited
|
|
Notes
|
31st July 2024
|
|
31st July 2023
|
|
31st January 2024
|
|
|
£'000
|
£'000
|
|
£'000
|
£'000
|
|
£'000
|
£'000
|
ASSETS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NON-CURRENT ASSETS
|
|
|
|
|
|
|
|
|
|
Property, plant and
equipment
|
|
59
|
|
|
72
|
|
|
65
|
|
Right-of-use asset
|
|
425
|
|
|
590
|
|
|
507
|
|
Investments - equity
portfolio
|
4
|
153,446
|
|
|
133,489
|
|
|
115,833
|
|
Loans and receivables
|
|
21,017
|
|
|
13,741
|
|
|
16,197
|
|
|
|
|
174,947
|
|
|
147,892
|
|
|
132,602
|
CURRENT ASSETS
|
|
|
|
|
|
|
|
|
|
Investments - assets held for
sale
|
|
-
|
|
|
52,326
|
|
|
49,549
|
|
Investments - treasury
portfolio
|
5
|
-
|
|
|
80
|
|
|
78
|
|
Trade and other
receivables
|
|
7,927
|
|
|
6,415
|
|
|
15,633
|
|
Cash and cash equivalents
|
|
80,233
|
|
|
4,257
|
|
|
40,435
|
|
|
|
|
88,160
|
|
|
63,078
|
|
|
105,695
|
LIABILITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NON-CURRENT LIABILITIES
|
|
|
|
|
|
|
|
|
|
Lease liabilities
|
|
(315)
|
|
|
(505)
|
|
|
(416)
|
|
Deferred tax liabilities
|
9
|
(9,081)
|
|
|
(5,604)
|
|
|
(6,687)
|
|
|
|
|
(9,396)
|
|
|
(6,109)
|
|
|
(7,103)
|
CURRENT LIABILITIES
|
|
|
|
|
|
|
|
|
|
Trade and other payables
|
|
(649)
|
|
|
(1,226)
|
|
|
(1,843)
|
|
Lease liabilities
|
|
(189)
|
|
|
(180)
|
|
|
(180)
|
|
|
|
|
(838)
|
|
|
(1,406)
|
|
|
(2,023)
|
|
|
|
|
|
|
|
|
|
|
NET
ASSETS
|
|
|
£252,873
|
|
|
£203,455
|
|
|
£229,171
|
|
|
|
|
|
|
|
|
|
|
CAPITAL AND RESERVES - EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Called up share capital
|
|
|
3,729
|
|
|
3,747
|
|
|
3,729
|
Share premium account
|
|
|
29,351
|
|
|
29,348
|
|
|
29,345
|
Fair value reserve
|
|
|
88,941
|
|
|
121,291
|
|
|
112,768
|
Reverse acquisition
reserve
|
|
|
393
|
|
|
393
|
|
|
393
|
Capital redemption reserve
|
|
|
25
|
|
|
7
|
|
|
25
|
Capital contribution
reserve
|
|
|
72
|
|
|
72
|
|
|
72
|
Retained earnings
|
|
|
130,362
|
|
|
48,597
|
|
|
82,839
|
|
|
|
|
|
|
|
|
|
|
SHAREHOLDERS' FUNDS - EQUITY
|
7
|
|
£252,873
|
|
|
£203,455
|
|
|
£229,171
|
|
|
|
|
|
|
|
|
|
|
Net Asset Value per share - undiluted
(pence)
|
3
|
|
690.8p
|
|
|
567.3p
|
|
|
629.0p
|
Net Asset Value per share - diluted
(pence)
|
3
|
|
658.5p
|
|
|
556.3p
|
|
|
626.9p
|
The Interim Consolidated Financial
Statements were approved by the Board of Directors and authorised
for issue on 22nd October 2024
and signed on its behalf
by:
B.P. Marsh & F.L.
Chappell
​
CONSOLIDATED STATEMENT OF
CASH FLOWS
FOR THE PERIOD ENDED 31ST
JULY 2024
|
|
Unaudited
|
|
Unaudited
|
|
Audited
|
|
|
|
31st July 2024
|
|
31st July 2023
|
|
31st January 2024
|
|
|
|
£'000
|
|
£'000
|
|
£'000
|
|
Cash
from / (used by) operating activities
|
|
|
|
|
|
|
|
Income from loans to investee
companies
|
|
1,123
|
|
815
|
|
1,861
|
|
Dividends
|
|
2,368
|
|
2,280
|
|
3,504
|
|
Fees received
|
|
721
|
|
860
|
|
2,103
|
|
Operating expenses
|
|
(4,909)
|
|
(2,844)
|
|
(7,881)
|
|
Net corporation tax paid
|
|
(34)
|
|
(33)
|
|
(33)
|
|
Purchase of equity investments (Note
4)
|
|
(9,500)
|
|
(431)
|
|
(3,364)
|
|
Net proceeds from sale of equity
investments
|
|
42,079
|
|
791
|
|
53,117
|
|
Net loan repayments from / (payments
to) investee companies
|
|
9,700
|
|
(6,592)
|
|
(17,630)
|
|
Adjustment for non-cash share
incentive plan
|
|
216
|
|
58
|
|
186
|
|
Exchange movement
|
|
(3)
|
|
(49)
|
|
(53)
|
|
Decrease / (increase) in
receivables
|
|
810
|
|
(447)
|
|
(1,052)
|
|
(Decrease) / increase in
payables
|
|
(1,194)
|
|
(603)
|
|
13
|
|
Depreciation and
amortisation
|
|
93
|
|
94
|
|
191
|
|
Net
cash from / (used by) operating activities
|
|
41,470
|
|
(6,101)
|
|
30,962
|
|
|
|
|
|
|
|
|
|
Net
cash from investing activities
|
|
|
|
|
|
|
|
Purchase of property, plant and
equipment
|
|
(5)
|
|
(7)
|
|
(13)
|
|
Net proceeds from the sale of
treasury investments net of cash and cash equivalents
|
|
79
|
|
600
|
|
1,130
|
|
Net
cash from investing activities
|
|
74
|
|
593
|
|
1,117
|
|
|
|
|
|
|
|
|
|
Net cash used by financing activities
|
|
|
|
|
|
|
Financial income
|
|
1,566
|
|
-
|
|
87
|
|
Financial expenses
|
|
(86)
|
|
(20)
|
|
(39)
|
|
Net decrease in lease liabilities
|
|
(92)
|
|
(87)
|
|
(175)
|
|
Dividends paid (Note 7)
|
|
(3,964)
|
|
(1,000)
|
|
(2,028)
|
|
Payments made to repurchase company shares
|
|
(327)
|
|
(692)
|
|
(1,053)
|
|
Cash received in respect of JSOP shares sold
|
|
1,157
|
|
-
|
|
-
|
|
Net
cash used by financing activities
|
|
(1,746)
|
|
(1,799)
|
|
(3,208)
|
|
|
|
|
|
|
|
|
|
Change in cash and cash
equivalents
|
|
39,798
|
|
(7,307)
|
|
28,871
|
|
Cash and cash equivalents at
beginning of the period
|
|
40,435
|
|
11,564
|
|
11,564
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period
|
|
£80,233
|
|
£4,257
|
|
£40,435
|
|
|
|
|
|
|
All differences between the amounts
stated in the Consolidated Statement of Cash Flows and the
Consolidated Statement of Comprehensive Income are attributed to
non-cash movements
​
CONSOLIDATED STATEMENT OF
CHANGES IN EQUITY
FOR THE
PERIOD ENDED 31ST JULY 2024
|
|
Unaudited
|
Unaudited
|
Audited
|
|
|
6 months
to
|
6 months
to
|
Year
to
|
|
|
31st July 2024
|
31st July 2023
|
31st January 2024
|
|
|
£'000
|
£'000
|
£'000
|
|
|
|
|
|
Opening total equity
|
|
229,171
|
189,537
|
189,537
|
Comprehensive income for the
period
|
|
26,620
|
15,552
|
42,529
|
Dividends paid
|
|
(3,964)
|
(1,000)
|
(2,028)
|
Repurchase of company
shares
|
|
(327)
|
(692)
|
(1,053)
|
Share incentive and share option
plan
|
|
216
|
58
|
186
|
Amounts received from the Employee
Benefit Trust on the sale of shares held under joint
ownership
|
|
1,157
|
-
|
-
|
Total equity
|
|
£252,873
|
£203,455
|
£229,171
|
Refer to Note 7 for detailed
analysis of the changes in the components of equity.
NOTES TO THE CONSOLIDATED
FINANCIAL STATEMENTS
FOR THE
PERIOD ENDED 31ST JULY 2024
1.
ACCOUNTING
POLICIES
Basis of preparation of financial statements
These consolidated financial
statements have been prepared in accordance with UK-adopted
international accounting standards, and in accordance with the
Companies Act 2006.
The consolidated financial
statements are presented in sterling, the functional currency of
the Group, rounded to the nearest thousand pounds (£'000) except
where otherwise indicated.
The preparation of financial
statements in conformity with UK-adopted international accounting
standards requires management to make judgments, estimates and
assumptions that affect the application of policies and reported
amounts of assets and liabilities, income and expenses. The
estimates and associated assumptions are based on historical
experience and various other factors that are believed to be
reasonable in the circumstances, the results of which form the
basis of judgements about the carrying amounts of assets and
liabilities. Actual results may differ from those
amounts.
In the process of applying the
Group's accounting policies, management has made the following
judgments, which have the most significant effect on the amounts
recognised in the financial statements:
Assessment as an investment entity
Entities that meet the definition
of an investment entity within IFRS 10: Consolidated Financial
Statements ("IFRS 10") are required to account for their
investments in controlled entities, as well as investments in
associates at fair value through profit or loss. Subsidiaries that
provide investment related services or engage in permitted
investment related activities with investees that relate to the
parent investment entity's investment activities continue to be
consolidated in the Group results. The criteria which define an
investment entity are currently as follows:
a) an entity that
obtains funds from one or more investors for the purpose of
providing those investors with investment services;
b) an entity that
commits to its investors that its business purpose is to invest
funds solely for returns from capital appreciation, investment
income or both; and
c) an entity that
measures and evaluates the performance of substantially all of its
investments on a fair value basis.
The Group's annual and interim
consolidated financial statements clearly state its objective of
investing directly into portfolio investments and providing
investment management services to investors for the purpose of
generating returns in the form of investment income and capital
appreciation. The Group has always reported its investment in
portfolio investments at fair value. It also produces reports for
investors of the funds it manages and its internal management
report on a fair value basis. The exit strategy for all investments
held by the Group is assessed, initially, at the time of the first
investment and this is documented in the investment paper submitted
to the Board for approval.
The Board has also concluded that
the Company meets the additional characteristics of an investment
entity, in that it has more than one investment; the investments
are predominantly in the form of equities and similar securities;
it has more than one investor and its investors are not related
parties. The Board has concluded that B.P. Marsh & Partners Plc
and its two trading subsidiaries, B.P. Marsh & Company Limited
and B.P. Marsh (North America) Limited, which provide investment
related services on behalf of B.P. Marsh & Partners Plc, all
meet the definition of an investment entity. These conclusions will
be reassessed on an annual basis for changes to any of these
criteria or characteristics.
Application and significant judgments
When it is established that a
parent company is an investment entity, its subsidiaries are
measured at fair value through profit or loss. However, if an
investment entity has subsidiaries that provide services that
relate to the investment entity's investment activities, the
exception to the Amendment of IFRS 10 is not applicable as in this
case, the parent investment entity still consolidates the results
of its subsidiaries. Therefore, the results of B.P. Marsh &
Company Limited and B.P. Marsh (North America) Limited continue to
be consolidated into its Group financial statements for the
period.
The most significant estimates
relate to the fair valuation of the equity investment portfolio as
detailed in Note 4 to the Financial
Statements. The valuation methodology for the investment portfolio
is detailed below. The estimates and underlying assumptions are
reviewed on an ongoing basis. Revisions to accounting estimates are
recognised in the period in which the estimate is revised if the
revision affects only that period or in the period of the revision
and future periods if the revision affects both current and future
periods.
The accounting policies set out
below have been applied consistently to all periods presented in
these consolidated financial statements.
These interim consolidated
financial statements were approved by the Board on 22nd October
2024. They have not been audited nor reviewed by the Group's
Auditors, as is the case with the comparatives to 31st July 2023,
and do not constitute statutory accounts within the meaning of
section 434 of the Companies Act 2006.
The financial statements have been
prepared using the accounting policies and presentation that were
applied in the audited financial statements for the year ended 31st
January 2024. Those accounts, upon which the Group's Auditor issued
an unqualified opinion, have been filed with the Registrar of
Companies and do not contain a statement under section 498 (2) or
(3) of the Companies Act 2006.
Basis of consolidation
(i) Subsidiaries
Subsidiaries are entities
controlled by the Group. Control, as defined by IFRS 10, is
achieved when the Group is exposed, or has rights, to variable
returns from its involvement with the investee and has the ability
to affect those returns through its power over the investee.
Specifically, the Group controls an investee if and only if the
Group has:
a) power over the
investee (i.e. existing rights that give it the current ability to
direct the relevant activities of the investee);
b) exposure, or rights,
to variable returns from its involvement with the investee;
and
c) the ability to use
its power over the investee to affect its returns.
When the Group has less than a
majority of the voting or similar rights of an investee, the Group
considers all relevant facts and circumstances in assessing whether
it has power over an investee, including:
a) rights arising from
other contractual arrangements; and
b) the Group's voting
rights and potential voting rights.
The Group re-assesses whether or
not it controls an investee if facts and circumstances indicate
that there are changes to one or more of the elements of
control.
B.P. Marsh & Partners Plc ("the
Company"), an investment entity, has two subsidiary investment
entities, B.P. Marsh & Company Limited and B.P. Marsh (North
America) Limited, that provide services that relate to the
Company's investment activities. The results of these two
subsidiaries, together with other subsidiaries (except for LEBC
Holdings Limited ("LEBC")), are consolidated into the Group
consolidated financial statements. The Group has taken advantage of
the Amendment to IFRS 10 not to consolidate the results of LEBC.
Instead the investment in LEBC is valued at fair value through
profit or loss.
(ii) Associates
Associates are those entities in
which the Group has significant influence, but not control, over
the financial and operating policies. Investments that are held as
part of the Group's investment portfolio are carried in the
Consolidated Statement of Financial Position at fair value even
though the Group may have significant influence over those
companies.
Business Combinations
The results of subsidiary
undertakings are included in the consolidated financial statements
from the date that control commences until the date that control
ceases. Control exists where the Group has the power to govern the
financial and operating policies of the entity so as to obtain
benefits from its activities. Accounting policies of the
subsidiaries have been changed where necessary to ensure
consistency with the policies adopted by the
Group.
All business combinations are
accounted for by using the acquisition accounting method. This
involves recognising identifiable assets and liabilities of the
acquired business at fair value. Goodwill represents the excess of
the fair value of the purchase consideration for the interests in
subsidiary undertakings over the fair value to the Group of the net
assets and any contingent liabilities acquired.
Intra-group balances and any
unrealised gains and losses or income and expenses arising from
intra-group transactions are eliminated in preparing the
consolidated financial statements.
Associates are those entities in
which the Group has significant influence, but not control, over
the financial and operating policies. Investments that are held as
part of the Group's investment portfolio are carried in the
Consolidated Statement of Financial Position at fair value even
though the Group may have significant influence over those
companies. This treatment is permitted by IAS 28: Investment in
Associates ("IAS 28"), which requires investments held by venture
capital organisations to be excluded from its scope where those
investments are designated, upon initial recognition, as at fair
value through profit or loss and accounted for in accordance with
IAS 39: Financial Instruments ("IAS 39"), with changes in fair
value recognised in the profit or loss in the period of the change.
The Group has no interests in associates through which it carries
on its business.
Employee services settled in equity
instruments
The Group has entered into a joint
share ownership plan ("JSOP") with certain employees and
directors.
On 12th June 2021 (the "vesting
date") the performance criteria was met for 1,206,888 of 1,461,302
shares held under joint share ownership arrangements within the
Employee Benefit Trust, after which the members of the scheme
became joint beneficial owners of the shares and became entitled to
any gain on sale of the shares in excess of 312.6 pence per
share.
On 26th October 2023 following the
removal of a dividend waiver and block on voting rights on the
1,206,888 allocated ordinary shares held by the Employee Benefit
Trust, these ordinary shares became eligible for dividend and
voting rights and therefore became fully dilutive for the
Group.
236,259 ordinary shares held within
the Employee Benefit Trust are unallocated and do not have voting
or dividend rights. The Employee Benefit Trust remains the owner of
these unallocated shares, however if these shares are sold from the
Employee Benefit Trust in the future they would then, post-sale,
have voting and dividend rights attached, such that they would
become fully dilutive for the Group.
Provided that the shares are
eventually sold from the Employee Benefit Trust for at least 284.5
pence per share on average, the Group would be entitled to receive
£4,106,259 in total.
The Group has established an HMRC
approved Share Incentive Plan ("SIP"). Ordinary shares in the
Company previously repurchased and held in Treasury by the Company
have been transferred to The B.P. Marsh SIP Trust ("the SIP
Trust"), an employee share trust, in order to be issued to eligible
employees.
Under the rules of the SIP,
eligible employees can each be granted up to £3,600 worth of
ordinary shares ("Free Shares") by the SIP Trust in each tax year.
The number of shares granted is dependent on the share price at the
date of grant. In addition, all eligible employees have been
invited to take up the opportunity to acquire up to £1,800 worth of
ordinary shares ("Partnership Shares") in each tax year and for
every Partnership Share that an employee acquires, the SIP Trust
will offer two ordinary shares in the Company ("Matching Shares")
up to a total of £3,600 worth of shares. The Free and Matching
Shares are subject to a one year forfeiture period, however the
awards are not subject to any vesting conditions, hence the related
expenses are recognised when the awards are made and are
apportioned over the forfeiture period.
The fair value of the services
received is measured by reference to the listed share price of the
parent company's shares listed on the AIM on the date of award of
the free and matching shares to the employee.
The Group has also established a
Share Option Plan ("SOP") for certain employees and directors.
Share Options ("Options") over 1,682,500 ordinary shares of 10p
each in the Company, in aggregate, have been granted. 3,470 Options
of the total 1,685,970 available for allocation are
unallocated.
Each of the Options will vest, on a
ratchet basis, subject to certain Net Asset Value growth targets
being achieved for the three consecutive financial years ending
31st January 2024, 31st January 2025 and 31st January 2026 (the
"Performance Period"). The first exercise date is 6th September
2026 whereby 50% of vested Options will be exercisable at 10p per
share, with the remaining 50% exercisable at 10p per share from 6th
September 2027.
The number of Options which vest
will vary depending on the level of Net Asset Value growth
achieved, subject to the growth performance criteria as set out
below, alongside the percentage of Options that will vest at each
value:
Compounded annual growth of Net Asset Value over the
Performance Period
|
% vesting of
Options
|
Less than 8.5%
|
0%
|
Between 8.5% and less than
9.25%
|
25%
|
Between 9.25% and less than
10%
|
50%
|
10% or above
|
100%
|
For these purposes, Net Asset Value
is defined as "audited Total Assets less Total Liabilities for the
consolidated Group plus any dividends or other form of shareholder
return that are paid in the relevant Financial Year".
Therefore, for all Options to vest,
the Net Asset Value (as defined above) would need to exceed
£252.2m, adjusted for any shareholder distributions.
Investments - equity
portfolio
All equity portfolio investments
are designated as "fair value through profit or loss" assets and
are initially recognised at the fair value of the consideration.
They are measured at subsequent reporting dates at fair
value.
The Board conducts the valuations
of equity portfolio investments. In valuing equity portfolio
investments the Board applies guidelines issued by the
International Private Equity and Venture Capital Valuation
Committee ("IPEVCV Guidelines"). The following valuation
methodologies have been used in reaching fair value of equity
portfolio investments, some of which are in early stage
companies:
a) at cost, unless
there has been a significant round of new equity finance in which
case the investment is valued at the price paid by an independent
third party. Where subsequent events or changes to circumstances
indicate that an impairment may have occurred, the carrying value
is reduced to reflect the estimated extent of
impairment;
b) by reference to
underlying funds under management;
c) by applying
appropriate multiples to the earnings and revenues and/or premiums
of the investee company; or
d) by reference to
expected future cash flow from the investment where a realisation
or flotation is imminent.
Both realised and unrealised gains
and losses arising from changes in fair value are taken to the
Consolidated Statement of Comprehensive Income for the period. In
the Consolidated Statement of Financial Position the unrealised
gains and losses arising from changes in fair value are shown
within a "fair value reserve" separate from retained earnings.
Transaction costs on acquisition or disposal of equity portfolio
investments are expensed in the Consolidated Statement of
Comprehensive Income.
Equity portfolio investments are
treated as 'Non-current Assets' within the Consolidated Statement
of Financial Position unless the directors have committed to a plan
to sell the investment and an active programme to locate a buyer
and complete the plan has been initiated. Where such a commitment
exists, and if the carrying amount of the equity portfolio
investment will be recovered principally through a sale transaction
rather than through continuing use, the investment is classified as
an 'Investments - Assets held for sale' under 'Current Assets'
within the Consolidated Statement of Financial Position.
Income from equity portfolio investments
Income from equity portfolio
investments comprises:
a) gross interest from
loans, which is taken to the Consolidated Statement of
Comprehensive Income on an accruals basis;
b) dividends from
equity investments are recognised in the Consolidated Statement of
Comprehensive Income when the shareholders rights to receive
payment have been established; and
c) advisory fees from
management services provided to investee companies, which are
recognised on an accruals basis in accordance with the substance of
the relevant investment advisory agreement.
Investments - treasury portfolio
All treasury portfolio investments
are designated as "fair value through profit or loss" assets and
are initially recognised at the fair value of the consideration.
They are measured at subsequent reporting dates at fair market
value as determined from the valuation reports provided by the fund
investment manager.
Both realised and unrealised gains
and losses arising from changes in fair market value are taken to
the Consolidated Statement of Comprehensive Income for the period.
In the Consolidated Statement of Financial Position the unrealised
gains and losses arising from changes in fair value are shown
within the retained earnings as these investments are deemed as
being easily convertible into cash. Costs associated with the
management of these investments are expensed in the Consolidated
Statement of Comprehensive Income.
Income from treasury portfolio investments
Income from treasury portfolio
investments comprises of dividends receivable which are either
directly reinvested into the funds or received as
cash.
Property, plant and equipment
Property, plant and equipment are stated at cost
less depreciation. Depreciation is provided at rates calculated to
write off the property, plant and equipment cost, less their
estimated residual value, over their expected useful lives on the
following bases:
Furniture & equipment -
5 years
Leasehold fixtures and
fittings and other costs - over the life of the lease
Right-of-use asset
IFRS 16 requires lessees to recognise a lease
liability, representing the present value of the obligation to make
lease payments, and a related right of use ("ROU") asset. The lease
liability is calculated based on expected future lease payments,
discounted using the relevant incremental borrowing rate. An
incremental borrowing rate of 5% was used to discount the future
lease payments when measuring the lease liability on adoption of
IFRS 16.
The ROU asset is recognised at cost less accumulated
depreciation and impairment losses, with depreciation charged on a
straight-line basis over the life of the lease. In determining the
value of the ROU asset and lease liabilities, the Group considers
whether any leases contain lease extensions or termination options
that the Group is reasonably certain to exercise.
Foreign currencies
Monetary assets and liabilities
denominated in foreign currencies at the reporting period end are
translated at the exchange rate ruling at the reporting period
end.
Transactions in foreign currencies
are translated into sterling at the foreign exchange rate ruling at
the date of the transaction.
Exchange gains and losses are
recognised in the Consolidated Statement of Comprehensive
Income.
Income taxes
The tax credit or expense
represents the sum of the tax currently recoverable or payable and
any deferred tax. The tax currently recoverable or payable is based
on the estimated taxable profit for the year. Taxable profit
differs from net profit as reported in the Consolidated Statement
of Comprehensive Income because it excludes items of income or
expense that are taxable or deductible in other years and it
further excludes items that are never taxable or deductible. The
Group's receivable or liability for current tax is calculated using
tax rates that have been enacted or substantively enacted by the
date of the Consolidated Statement of Financial
Position.
Deferred tax is the tax expected to
be payable or recoverable on differences between the carrying
amounts of assets and of liabilities in the financial statements
and the corresponding tax bases used in the computation of taxable
profit, and it is accounted for using the liability method.
Deferred tax liabilities are generally recognised for all taxable
temporary differences and deferred tax assets are recognised to the
extent that it is probable that taxable profits will be available
against which deductible temporary differences can be utilised.
Such assets and liabilities are not recognised if the temporary
differences arise from goodwill or from the initial recognition
(other than in a business combination) of other assets and
liabilities in a transaction that affects neither the taxable
profit nor the accounting profit.
Deferred tax liabilities are
recognised for taxable temporary differences arising on investments
in subsidiaries, except where the Group is able to control the
reversal of the temporary difference and it is probable that the
temporary difference will not reverse in the foreseeable
future.
The carrying amount of deferred tax
assets is reviewed at each date of the Consolidated Statement of
Financial Position and reduced to the extent that it is no longer
probable that sufficient taxable profits will be available to allow
all or part of the asset to be recovered.
Deferred tax is calculated at the
tax rates that are expected to apply in the period when the
liability is settled or the asset realised. Deferred tax is charged
or credited to the Consolidated Statement of Comprehensive Income,
except when it relates to items charged or credited directly to
equity, in which case the deferred tax is also dealt with in
equity.
Deferred tax assets and liabilities
are offset when there is a legally enforceable right to set off
current tax assets against current tax liabilities and when they
relate to income taxes levied by the same taxation authority and
the Group intends to settle its current assets and liabilities on a
net basis.
2. SEGMENTAL REPORTING
The Group operates in one business
segment; the provision of consultancy services to as well as making
and trading investments in financial services
businesses.
Under IFRS 8: Operating Segments
("IFRS 8") the Group identifies its reportable operating segments
based on the geographical location in which each of its investments
is incorporated and primarily operates. For management purposes,
the Group is organised and reports its performance by two
geographic segments: UK and Non-UK.
If material to the Group overall
(where the segment revenues, reported profit or loss or combined
assets exceed the quantitative thresholds prescribed by IFRS 8),
the segment information is reported separately.
The Group allocates revenues,
expenses, assets and liabilities to the operating segment where
directly attributable to that segment. All indirect items are
apportioned based on the percentage proportion of revenue that the
operating segment contributes to the total Group revenue (excluding
any realised and unrealised gains and losses on the Group's current
and non-current investments).
Each reportable segment derives its
revenues from three main sources from equity portfolio investments
as described in further detail in Note 1 under 'Income from equity
portfolio investments' and also from treasury portfolio investments
as described in Note 1 under 'Income from treasury portfolio
investments'.
All reportable segments derive
their revenues entirely from external clients and there are no
inter-segment sales.
|
Geographic segment 1:
UK
|
Geographic segment 2:
Non-UK
|
Group
|
|
|
|
|
|
|
|
|
Unaudited
|
Unaudited
|
Unaudited
|
Unaudited
|
Unaudited
|
Unaudited
|
|
6 months
to 31st July
|
6 months
to 31st July
|
6 months
to 31st July
|
6 months
to 31st July
|
6 months
to 31st July
|
6 months
to 31st July
|
|
2024
|
2023
|
2024
|
2023
|
2024
|
2023
|
|
|
|
|
|
|
|
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
Operating income
|
16,359
|
15,432
|
16,148
|
3,249
|
32,507
|
18,681
|
Operating expenses
|
(2,741)
|
(1,532)
|
(2,168)
|
(1,312)
|
(4,909)
|
(2,844)
|
Segment operating profit
|
13,618
|
13,900
|
13,980
|
1,937
|
27,598
|
15,837
|
|
|
|
|
|
|
|
Financial income
|
874
|
51
|
692
|
44
|
1,566
|
95
|
Financial expenses
|
(48)
|
(13)
|
(38)
|
(12)
|
(86)
|
(25)
|
Exchange movements
|
(9)
|
(43)
|
(21)
|
(306)
|
(30)
|
(349)
|
Profit before tax
|
14,435
|
13,895
|
14,613
|
1,663
|
29,048
|
15,558
|
Income taxes
|
-
|
-
|
(2,428)
|
(6)
|
(2,428)
|
(6)
|
Profit for the period
|
£14,435
|
£13,895
|
£12,185
|
£1,657
|
£26,620
|
£15,552
|
Included within the operating
income reported above are the following amounts requiring separate
disclosure owing to the fact that they are derived from a single
investee company and the total revenues attributable to that
investee company are 10% or more of the total realised and
unrealised income generated by the Group during the
period:
|
Total
net operating income attributable to the investee
company
(£'000)
|
% of
total realised and unrealised operating income
|
Reportable geographic segment
|
|
|
|
|
|
|
|
|
Unaudited
|
Unaudited
|
Unaudited
|
Unaudited
|
Unaudited
|
Unaudited
|
|
6 months
to 31st July
|
6 months
to 31st July
|
6 months
to 31st July
|
6 months
to 31st July
|
6 months
to 31st July
|
6 months
to 31st July
|
|
2024
|
2023
|
2024
|
2023
|
2024
|
2023
|
Investee Company
|
|
|
|
|
|
|
Pantheon Specialty Group
Limited1
|
11,232
|
-
|
35
|
-
|
1
|
-
|
XPT Group
LLC1
|
9,126
|
-
|
28
|
-
|
2
|
-
|
ATC Insurance Solutions PTY
Limited1
|
5,600
|
-
|
17
|
-
|
2
|
-
|
Lilley Plummer Holdings
Limited
|
4,157
|
2,072
|
13
|
11
|
1
|
1
|
Paladin Holdings
Limited1
|
-
|
11,984
|
-
|
64
|
-
|
1
|
1There is no disclosure for
Paladin Holdings Limited in the current period as the income
derived from this investee company did not exceed the 10% threshold
prescribed by IFRS 8 and it was sold during the period. There are
also no disclosures shown for Pantheon Specialty Group Limited, XPT
Group LLC and ATC Insurance Solutions PTY Limited in the prior
period as the income derived from these investee companies did not
exceed the 10% threshold prescribed by IFRS 8 in that
period.
|
Geographic segment 1:
UK
|
Geographic segment 2:
Non-UK
|
Group
|
|
|
|
|
|
|
|
|
Unaudited
|
Unaudited
|
Unaudited
|
Unaudited
|
Unaudited
|
Unaudited
|
|
6 months
to 31st July
|
6 months
to 31st July
|
6 months
to 31st July
|
6 months
to 31st July
|
6 months
to 31st July
|
6 months
to 31st July
|
|
2024
|
2023
|
2024
|
2023
|
2024
|
2023
|
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
|
|
|
|
|
|
|
Non-current assets
|
|
|
|
|
|
|
Property, plant and
equipment
|
23
|
43
|
36
|
29
|
59
|
72
|
Right-of-use asset
|
167
|
355
|
258
|
235
|
425
|
590
|
Investments - equity
portfolio
|
60,308
|
59,398
|
93,138
|
74,091
|
153,446
|
133,489
|
Loans and receivables
|
15,739
|
8,291
|
5,278
|
5,450
|
21,017
|
13,741
|
|
76,237
|
68,087
|
98,710
|
79,805
|
174,947
|
147,892
|
Current assets
|
|
|
|
|
|
|
Investments - assets held for
sale
|
-
|
52,326
|
-
|
-
|
-
|
52,326
|
Investments - treasury
portfolio
|
-
|
80
|
-
|
-
|
-
|
80
|
Trade and other
receivables
|
7,047
|
5,077
|
880
|
1,338
|
7,927
|
6,415
|
Cash and cash
equivalents
|
80,233
|
4,257
|
-
|
-
|
80,233
|
4,257
|
|
87,280
|
61,740
|
880
|
1,338
|
88,160
|
63,078
|
|
|
|
|
|
|
|
Total assets
|
163,517
|
129,827
|
99,590
|
81,143
|
263,107
|
210,970
|
|
|
|
|
|
|
|
Non-current liabilities
|
|
|
|
|
|
|
Lease liabilities
|
(124)
|
(304)
|
(191)
|
(201)
|
(315)
|
(505)
|
Deferred tax liabilities
|
-
|
-
|
(9,081)
|
(5,604)
|
(9,081)
|
(5,604)
|
|
(124)
|
(304)
|
(9,272)
|
(5,805)
|
(9,396)
|
(6,109)
|
Current liabilities
|
|
|
|
|
|
|
Trade and other payables
|
(644)
|
(1,223)
|
(5)
|
(3)
|
(649)
|
(1,226)
|
Lease liabilities
|
(74)
|
(108)
|
(115)
|
(72)
|
(189)
|
(180)
|
|
(718)
|
(1,331)
|
(120)
|
(75)
|
(838)
|
(1,406)
|
|
|
|
|
|
|
|
Total liabilities
|
(842)
|
(1,635)
|
(9,392)
|
(5,880)
|
(10,234)
|
(7,515)
|
|
|
|
|
|
|
|
Net assets
|
£162,675
|
£128,192
|
£90,198
|
£75,263
|
£252,873
|
£203,455
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additions to property, plant and equipment
|
2
|
3
|
3
|
4
|
5
|
7
|
|
|
|
|
|
|
|
Depreciation and amortisation of property, plant and
equipment
|
(36)
|
(56)
|
(57)
|
(38)
|
(93)
|
(94)
|
|
|
|
|
|
|
|
Net (provision) / release of provision against investments and
loans
|
(16)
|
12
|
-
|
-
|
(16)
|
12
|
|
|
|
|
|
|
|
Cash flow arising from:
|
|
|
|
|
|
|
Operating activities
|
42,525
|
(6,638)
|
(1,055)
|
537
|
41,470
|
(6,101)
|
Investing activities
|
74
|
593
|
-
|
-
|
74
|
593
|
Financing activities
|
(1,746)
|
(1,799)
|
-
|
-
|
(1,746)
|
(1,799)
|
Change in cash and cash equivalents
|
40,853
|
(7,844)
|
(1,055)
|
537
|
39,798
|
(7,307)
|
|
|
|
|
|
|
|
|
Geographic segment 1:
UK
|
Geographic segment 2:
Non-UK
|
Group
|
|
|
|
|
|
Audited
|
Audited
|
Audited
|
|
31st January
|
31st January
|
31st January
|
|
2024
|
2024
|
2024
|
|
£'000
|
£'000
|
£'000
|
|
|
|
|
Operating income
|
45,345
|
5,821
|
51,166
|
Operating expenses
|
(4,356)
|
(3,525)
|
(7,881)
|
Segment operating profit
|
40,989
|
2,296
|
43,285
|
|
|
|
|
Financial income
|
399
|
322
|
721
|
Financial expenses
|
(31)
|
(24)
|
(55)
|
Exchange movements
|
(39)
|
(294)
|
(333)
|
Profit before tax
|
41,318
|
2,300
|
43,618
|
Income taxes
|
-
|
(1,089)
|
(1,089)
|
Profit for the year
|
£41,318
|
£1,211
|
£42,529
|
Included within the operating
income reported above are the following amounts requiring separate
disclosure owing to the fact that they are derived from a single
investee company and the total revenues attributable to that
investee company are 10% or more of the total realised and
unrealised income generated by the Group during the
period:
|
Total
net operating income attributable to the investee
company
(£'000)
|
% of
total realised and unrealised operating income
|
Reportable geographic segment
|
|
|
|
|
|
Audited
|
Audited
|
Audited
|
|
31st January
|
31st January
|
31st January
|
|
2024
|
2024
|
2024
|
Investee Company
|
|
|
|
Paladin Holdings Limited
|
32,382
|
63
|
1
|
Pantheon Specialty Group
Limited
|
14,955
|
29
|
1
|
Lilley Plummer Holdings
Limited
|
6,888
|
13
|
1
|
|
|
|
|
|
Geographic segment 1:
UK
|
Geographic segment 2:
Non-UK
|
Group
|
|
|
|
|
|
Audited
|
Audited
|
Audited
|
|
31st January
|
31st January
|
31st January
|
|
2024
|
2024
|
2024
|
|
£'000
|
£'000
|
£'000
|
Non-current assets
|
|
|
|
Property, plant and
equipment
|
34
|
31
|
65
|
Right-of-use asset
|
268
|
239
|
507
|
Investments - equity
portfolio
|
37,783
|
78,050
|
115,833
|
Loans and receivables
|
10,775
|
5,422
|
16,197
|
|
48,860
|
83,742
|
132,602
|
Current assets
|
|
|
|
Investments - assets held for
sale
|
49,549
|
-
|
49,549
|
Investments - treasury
portfolio
|
78
|
-
|
78
|
Trade and other
receivables
|
14,840
|
793
|
15,633
|
Cash and cash
equivalents
|
40,435
|
-
|
40,435
|
|
104,902
|
793
|
105,695
|
|
|
|
|
Total assets
|
153,762
|
84,535
|
238,297
|
|
|
|
|
Non-current liabilities
|
|
|
|
Lease liabilities
|
(220)
|
(196)
|
(416)
|
Deferred tax liabilities
|
-
|
(6,687)
|
(6,687)
|
|
(220)
|
(6,883)
|
(7,103)
|
|
|
|
|
Current liabilities
|
|
|
|
Trade and other payables
|
(1,838)
|
(5)
|
(1,843)
|
Lease liabilities
|
(95)
|
(85)
|
(180)
|
|
(1,933)
|
(90)
|
(2,023)
|
|
|
|
|
Total liabilities
|
(2,153)
|
(6,973)
|
(9,126)
|
|
|
|
|
Net assets
|
£151,609
|
£77,562
|
£229,171
|
|
|
|
|
Additions to property, plant and equipment
|
7
|
6
|
13
|
|
|
|
|
Depreciation and amortisation of property, plant and
equipment
|
(101)
|
(90)
|
(191)
|
|
|
|
|
Release of provision against investments and
loans
|
24
|
-
|
24
|
|
|
|
|
Cash flow arising from:
|
|
|
|
Operating activities
|
37,534
|
(6,572)
|
30,962
|
Investing activities
|
1,117
|
-
|
1,117
|
Financing activities
|
(3,208)
|
-
|
(3,208)
|
Change in cash and cash equivalents
|
35,443
|
(6,572)
|
28,871
|
As outlined previously, under IFRS
8 the Group reports its operating segments (UK and Non-UK) and
associated income, expenses, assets and liabilities based upon the
country of domicile of each of its investee companies.
In addition to the segmental
analysis disclosure reported above, the Group has undertaken a
further assessment of each of its investee companies' underlying
revenues, specifically focusing on the geographical origin of this
revenue. Geographical analysis of each investee company's 2024 and
2023 revenue budgets was carried out and, based upon this analysis,
the directors have determined that on a look-through basis, the
Group's portfolio of investee companies can also be analysed as
follows:
|
|
Unaudited
|
|
Unaudited
|
|
Audited
|
|
|
31st July 2024
|
|
31st July 2023
|
|
31st January 2024
|
|
|
%
|
|
%
|
|
%
|
|
|
|
|
|
|
|
UK
|
|
23
|
|
36
|
|
29
|
Non-UK
|
|
77
|
|
64
|
|
71
|
Total
|
|
100
|
|
100
|
|
100
|
3. EARNINGS AND NET ASSET VALUE
PER SHARE FROM CONTINUING OPERATIONS ATTRIBUTABLE TO THE EQUITY
SHAREHOLDERS
|
|
Unaudited
|
|
Unaudited
|
|
Audited
|
|
|
31st July 2024
|
|
31st July 2023
|
|
31st January 2024
|
|
|
£'000
|
|
£'000
|
|
£'000
|
Earnings
|
|
|
|
|
|
|
Earnings for the purposes of basic
and diluted earnings per share being total comprehensive income
attributable to equity shareholders
|
|
26,620
|
|
15,552
|
|
42,529
|
Earnings per share - basic
|
|
72.0p
|
|
43.3p
|
|
114.7p
|
Earnings per share -
diluted
|
|
68.4p
|
|
41.6p
|
|
114.0p
|
|
|
|
|
|
|
|
Number of shares
|
|
Number
|
|
Number
|
|
Number
|
Weighted average number of ordinary
shares for the purposes of basic earnings per share
|
|
36,972,204
|
|
35,958,783
|
|
37,081,306
|
|
|
|
|
|
|
|
Number of dilutive shares under
option
|
|
1,918,759
|
|
1,443,147
|
|
236,259
|
|
|
|
|
|
|
|
Weighted average number of ordinary
shares for the purposes of dilutive earnings per share
|
|
38,890,963
|
|
37,401,930
|
|
37,317,565
|
|
|
|
|
|
|
|
|
|
Unaudited
|
|
Unaudited
|
|
Audited
|
|
|
31st July 2024
|
|
31st July 2023
|
|
31st January 2024
|
|
|
£'000
|
|
£'000
|
|
£'000
|
Net
Asset Value
|
|
|
|
|
|
|
Basic Net Asset Value
|
|
|
|
|
|
|
Net Asset Value attributable to
equity shareholders
|
|
252,873
|
|
203,455
|
|
229,171
|
Adjustment to Net Asset
Value1
|
|
2,255
|
|
-
|
|
3,391
|
Adjusted Net Asset Value for the
purposes of basic Net Asset Value per share being total Net Asset
Value attributable to equity shareholders
|
|
255,128
|
|
203,455
|
|
232,562
|
|
|
|
|
|
|
|
Diluted Net Asset Value
|
|
|
|
|
|
|
Net Asset Value attributable to
equity shareholders
|
|
252,873
|
|
203,455
|
|
229,171
|
Adjustment to Net Asset
Value2
|
|
2,949
|
|
4,055
|
|
4,106
|
Adjusted Net Asset Value for the
purposes of diluted Net Asset Value per share being total Net Asset
Value attributable to equity shareholders
|
|
255,822
|
|
207,510
|
|
233,277
|
|
|
|
|
|
|
|
Net Asset Value per share -
basic
|
|
690.8p
|
|
567.3p
|
|
629.0p
|
Net Asset Value per share -
diluted
|
|
658.5p
|
|
556.3p
|
|
626.9p
|
|
|
|
|
|
|
|
Number of shares
|
|
Number
|
|
Number
|
|
Number
|
Number of ordinary shares for the
purposes of basic Net Asset Value per share
|
|
36,933,439
|
|
35,860,775
|
|
36,974,191
|
|
|
|
|
|
|
|
Number of dilutive shares under
option
|
|
1,918,759
|
|
1,443,147
|
|
236,259
|
|
|
|
|
|
|
|
Number of ordinary shares for the
purposes of dilutive Net Asset Value per share
|
|
38,852,198
|
|
37,303,922
|
|
37,210,450
|
|
|
|
|
|
|
|
1Adjustment to Net Asset Value represents the cash receivable
by the Group when the 802,440 remaining allocated ordinary shares
that are held under joint ownership arrangements within the
Employee Benefit Trust, and which were considered fully dilutive as
at 31st July 2024, are sold.
2Adjustment to Net Asset Value represents the cash receivable
by the Group when the total remaining 1,038,699 (31st July 2023 and
31st January 2024: 1,443,147) allocated and unallocated ordinary
shares that are held under joint ownership arrangements within the
Employee Benefit Trust, are sold.
During the period the Company paid
a total of £327,120, including commission, in order to repurchase
63,132 ordinary shares at an average price of 517 pence per share
(6 months to 31st July 2023: the Company paid £691,820, including
commission, in order to repurchase 190,008 ordinary shares at an
average price of 363 pence per share and 12 months to 31st January
2024: the Company paid £1,052,751, including commission, to
repurchase 283,480 ordinary shares at an average price of 370 pence
per share).
Ordinary shares held by the Company in Treasury
Movement of ordinary shares held in
Treasury:
|
Unaudited
|
Unaudited
|
Audited
|
|
31st July 2024
|
31st July 2023
|
31st January 2024
|
|
Number
|
Number
|
Number
|
|
|
|
|
Opening total ordinary shares held
in Treasury
|
77,550
|
4,850
|
4,850
|
|
|
|
|
Ordinary shares repurchased into
Treasury during the period
|
63,132
|
190,008
|
283,480
|
|
|
|
|
Ordinary shares transferred to the
B.P. Marsh SIP Trust during the period
|
(22,380)
|
(32,780)
|
(32,780)
|
|
|
|
|
Ordinary shares cancelled from
Treasury during the period
|
-
|
-
|
(178,000)
|
|
|
|
|
Total ordinary shares held in Treasury at period
end
|
118,302
|
162,078
|
77,550
|
|
|
|
|
The Treasury shares do not have
voting or dividend rights and have therefore been excluded for the
purposes of calculating earnings per share and Net Asset Value per
share.
The repurchase of the ordinary
shares is borne from the Group's commitment to reduce share price
discount to Net Asset Value. As outlined in the Group's Share
Buy-Back Policy announcement on 14th November 2023, its policy has
been throughout the period, subject to ordinary shares in the
Company being available to purchase, to be able to buy small
parcels of shares (for up to a maximum aggregate consideration of
£500,000) at a price representing a discount of at least 20% to the
most recently announced Net Asset Value per share and place them
into Treasury. Prior to 14th November 2023, and in accordance with
its Share Buy-Back Policy announcement on 16th January 2023, the
Group's policy was to buy back shares when the share price was
below 20% of its published Net Asset Value (for up to a maximum
aggregate consideration of £1,000,000).
On 11th June 2024 the Group
announced a new Share Buy-Back Programme allowing it to repurchase
ordinary shares in the Company for up to a maximum aggregate
consideration of £1,000,000 and subject to ordinary shares being
available to purchase at a price representing a discount of at
least 15% to the most recently announced diluted Net Asset Value
per share.
Since 31st July 2024 the Group has
revised the maximum purchase price under the Share Buy-Back
Programme to enable it to repurchase ordinary shares up to a price
representing a discount of at least 10% to the most recently
announced diluted Net Asset Value per share.
As at 31st July 2023 and 31st
January 2024 there were 1,443,147 shares held within the Employee
Benefit Trust, of which 236,259 shares were unallocated. The
Employee Benefit Trust remains the owner of these unallocated
shares.
Following the removal of a dividend
waiver and block on voting rights on the 1,206,888 allocated
ordinary shares held by the Employee Benefit Trust under the Joint
Share Ownership Plan ("JSOP") in October 2023, these ordinary
shares became eligible for full dividend and voting
rights.
During the period 404,448 of the
shares held within the Employee Benefit Trust were sold, including
99,700 shares jointly-owned by 2 executive directors of the
Company. As at 31st July 2024 1,038,699 shares remained within the
Employee Benefit Trust, of which 236,259 were
unallocated.
The weighted average number of
shares used for the purposes of calculating the basic earnings per
share, net asset value and net asset value per share of the Group
includes the 802,440 remaining allocated ordinary shares held
within the Employee Benefit Trust as these were considered fully
dilutive as at 31st July 2024 due to the dividend and voting rights
attached to them. The Group net asset value also includes an
adjustment representing the economic right the Group has to the
first 281 pence per share (£2,254,856) on the 802,440 allocated
ordinary shares held within the Employee Benefit Trust as when the
joint share ownership arrangements are eventually exercised, this
would also increase the Group's net asset value by
£2,254,856.
236,259 unallocated shares
currently held within the Employee Benefit Trust have been excluded
for the purposes of calculating the basic earnings per share, net
asset value and net asset value per share as these shares do not
have voting rights or dividend rights whilst they are held within
this Employee Benefit Trust. The Group net asset value has also
excluded the economic right the Group has to the first 281 pence
per share on the 236,259 unallocated shares issued to the Employee
Benefit Trust for the same reasons.
On this basis the current undiluted
net asset value per share is 690.8 pence for the Group. When the
joint share ownership arrangements are eventually exercised in
full, although this would increase the number of shares in issue
entitled to voting and dividend rights, this would also increase
the Group's net asset value by a further £694,403 (total of
£4,106,259 based upon the total 1,461,302 shares originally issued
to the Employee Benefit Trust at 281 pence per share).
The diluted earnings per share and
net asset value per share include the 1,682,500 options over
ordinary shares granted as part of the Company's Share Option Plan
("SOP") as these became dilutive for the Group as at 31st July 2024
based upon the performance conditions attached to the options (Note
10).
The diluted net asset value per
share is therefore 658.5 pence.
The diluted weighted average number
of ordinary shares at 31st July 2024 has been calculated by
proportioning the 236,259 vested, but unallocated, shares held
under joint share ownership arrangements from the vesting date over
the period.
The decrease to the undiluted
weighted average number of ordinary shares between the 2023 and
2024 interim periods is mainly attributable to the 63,132 ordinary
shares repurchased into Treasury during the period, offset by the
22,380 ordinary shares transferred from Treasury to the SIP Trust
during the period that have been treated as re-issued for the
purposes of calculating earnings per share.
22,380 ordinary shares (comprising
22,380 ordinary shares transferred from Treasury to the SIP Trust
in April 2024) were allocated to the participating employees as
Free, Matching and Partnership shares under the share incentive
plan arrangement on 11th April 2024 (Note 10).
4. NON-CURRENT INVESTMENTS - EQUITY
PORTFOLIO
Group Investments
|
|
Unaudited
|
|
|
|
31st July
2024
|
|
|
|
|
|
|
|
|
|
Continuing investments
|
Current
Assets - Investments held for sale
|
Total
|
|
|
|
£'000
|
£'000
|
£'000
|
|
At
valuation
|
|
|
|
|
|
At 1st February
|
|
115,833
|
49,549
|
165,382
|
|
Additions
|
|
9,500
|
-
|
9,500
|
|
Disposals
|
|
-
|
(49,549)
|
(49,549)
|
|
Unrealised gains in this
period
|
|
28,113
|
-
|
28,113
|
|
|
|
|
|
|
|
At period end
|
|
£153,446
|
£
-
|
£153,446
|
|
|
|
|
|
|
|
At
cost
|
|
|
|
|
|
At 1st February
|
|
45,923
|
4
|
45,927
|
|
Additions
|
|
9,500
|
-
|
9,500
|
|
Disposals
|
|
-
|
(4)
|
(4)
|
|
|
|
|
|
|
|
At period end
|
|
£55,423
|
£
-
|
£55,423
|
|
|
|
|
|
|
|
|
|
Unaudited
|
|
|
|
31st July
2023
|
|
|
|
|
|
|
|
|
|
Continuing investments
|
Current
Assets - Investments held for sale
|
Total
|
|
|
|
£'000
|
£'000
|
£'000
|
|
At
valuation
|
|
|
|
|
|
At 1st February
|
|
171,461
|
-
|
171,461
|
|
Transfers between
categories
|
|
(52,326)
|
52,326
|
-
|
|
Additions
|
|
431
|
-
|
431
|
|
Disposals
|
|
(832)
|
-
|
(832)
|
|
Unrealised gains in this
period
|
|
14,755
|
-
|
14,755
|
|
|
|
|
|
|
|
At period end
|
|
£133,489
|
£52,326
|
£185,815
|
|
|
|
|
|
|
|
At
cost
|
|
|
|
|
|
At 1st February
|
|
59,321
|
-
|
59,321
|
|
Transfers between
categories
|
|
(12,927)
|
12,927
|
-
|
|
Additions
|
|
431
|
-
|
431
|
|
Disposals
|
|
(832)
|
-
|
(832)
|
|
|
|
|
|
|
|
At period end
|
|
£45,993
|
£12,927
|
£58,920
|
|
|
|
|
|
|
|
Group Investments (continued)
|
|
Audited
31st January
2024
|
|
|
|
|
|
|
|
|
|
Continuing investments
|
Current
Assets - Investments held for sale
|
Total
|
|
|
|
£'000
|
£'000
|
£'000
|
|
At
valuation
|
|
|
|
|
|
At 1st February
2023
|
|
171,461
|
-
|
171,461
|
|
Transfers between
categories
|
|
(18,380)
|
18,380
|
-
|
|
Additions
|
|
3,364
|
-
|
3,364
|
|
Disposals
|
|
(53,154)
|
-
|
(53,154)
|
|
Unrealised gains in this
period
|
|
12,542
|
31,169
|
43,711
|
|
|
|
|
|
|
|
At 31st January
2024
|
|
£115,833
|
£49,549
|
£165,382
|
|
|
|
|
|
|
|
At
cost
|
|
|
|
|
|
At 1st February
2023
|
|
59,321
|
-
|
59,321
|
|
Transfers between
categories
|
|
(4)
|
4
|
-
|
|
Additions
|
|
3,364
|
-
|
3,364
|
|
Disposals
|
|
(16,758)
|
-
|
(16,758)
|
|
|
|
|
|
|
|
At 31st January
2024
|
|
£45,923
|
£
4
|
£45,927
|
|
|
|
|
|
|
|
The additions relate to the
following transactions in the period:
On 27th March 2024 the Group
acquired a 30% cumulative preferred ordinary equity stake in
Devonshire UW Limited ("Devonshire") via a holding company,
Devonshire UW Topco Limited, for consideration of £300,000.
Devonshire is a London-based Underwriting Agency specialising in
transactional risks, including Warranty & Indemnity, Specific
Tax and Legal Contingency Insurance, with the ability to underwrite
transactions in the UK, Europe, Middle East, Africa, Asia, South
America, Central America and Australasia. The Group also provided
Devonshire with a loan facility of £1,600,000, of which £990,125
had been drawn down as at 31st July 2024, with a remaining undrawn
facility of £909,875.
On 17th April 2024, the Group
acquired a further 2.52% ordinary equity holding in LEBC Holdings
Limited ("LEBC") for consideration of £1,100,000. On completion the
ordinary shares were immediately converted into preferred shares.
The transaction increased the Group's holding in LEBC from 59.34%
as at 31st January 2024 to 61.86% as at 31st July 2024.
On 9th May 2024 the Group acquired
a further 7% cumulative preferred ordinary equity stake in Pantheon
Specialty Group Limited ("Pantheon") for consideration of
£7,300,000 increasing its equity holding from 25% as at 31st
January 2024 to 32% as at 31st July 2024.
On 13th May 2024 the Group
acquired, through its wholly-owned subsidiary company B.P. Marsh
(North America) Limited, a further 0.95% equity stake in XPT Group
LLC ("XPT") for USD 1,000,787 (£800,073) as part of a pre-emption
share offer. Following this investment, and the uptake of other
shareholder's pre-emptive rights and other dilutive events, the
Group's fully diluted shareholding in XPT reduced from 29.10% as at
31st January 2024 to 27.49% as at 31st July 2024.
The disposals relate to the
following transaction in the period:
On 22nd March 2024 the Group
completed the disposal of its entire 38.63% holding in Paladin
Holdings Limited ("Paladin") to Specialist Risk Group Limited
("SRG"), following receipt of regulatory approval. On completion,
the Group received £42,075,838 in initial cash consideration, net
of transaction costs, plus repayment in full of its £5,900,500
loans to Paladin. The initial cash proceeds received represented an
overall gain of £42,072,338 above the net cost of investment. As
well as the initial consideration, the Group will also be entitled
to receive its proportion of any net working capital adjustment.
The Group will then be entitled to receive deferred contingent
consideration of up to £17,800,000 in cash, based upon 20% EBITDA
growth targets above Paladin's actual adjusted EBITDA for 2023, in
FY24 and FY25, payable in 2025 and 2026. There is also the
possibility for the Group to receive further consideration in FY25
should Paladin outperform these growth targets.
The carrying value of the Group's
investment in Paladin as at 1st February 2024 was £49,549,000. A
proportion of this carrying value related to the Group's discounted
deferred contingent consideration estimate. On disposal, the fair
value attributed to the deferred contingent consideration
element of the sale amounting to £9,021,000 was reclassified within
the Consolidated Statement of Financial Position from 'Investments
- assets held for sale' to a debtor balance within 'Other
receivables'. As at 31st July 2024 the fair value of the deferred
contingent consideration was revalued at £7,668,000 and the
associated loss of £1,353,000 has been recognised within the
Consolidated Statement of Comprehensive Income.
The unquoted investee companies,
which are registered in England except Asia Reinsurance Brokers Pte
Limited (Singapore), Stewart Specialty Risk Underwriting Ltd
(Canada), XPT Group LLC (USA), ATC Insurance Solutions PTY Limited
(Australia), Criterion Underwriting Pte Limited (Singapore), Agri
Services Company PTY Limited (Australia) and Sage Program
Underwriters, Inc (USA) are as follows:
|
%
holding
|
Date
|
Aggregate
|
Post
tax
|
|
|
of
share
|
information
|
capital
and
|
profit/(loss)
|
|
Name of company
|
Capital
|
available to
|
reserves
|
for the
year
|
Principal activity
|
|
|
|
£
|
£
|
|
|
|
|
|
|
|
Agri Services Company PTY
Limited
|
41.00
|
30.06.23
|
1,465,168
|
64,998
|
Holding company for specialist
Australian agricultural Managing General Agency
|
|
|
|
|
|
|
Asia Reinsurance Brokers Pte
Limited
|
25.00
|
31.05.23
|
2,088,147
|
90,564
|
Specialist reinsurance
broker
|
|
|
|
|
|
|
ATC Insurance Solutions PTY
Limited
|
25.56
|
30.06.23
|
12,991,892
|
3,470,843
|
Specialist Australian Managing
General Agency
|
|
|
|
|
|
|
Criterion Underwriting Pte
Limited1
|
29.40
|
31.05.20
|
(445,842)
|
(32,019)
|
Specialist Singaporean Managing
General Agency
|
|
|
|
|
|
|
Dempsey Group
Limited2
|
30.00
|
-
|
-
|
-
|
Holding company for specialist
Managing General Agency
|
|
|
|
|
|
|
Devonshire UW Topco
Limited3
|
30.00
|
-
|
-
|
-
|
Specialist UK Managing General
Agency
|
|
|
|
|
|
|
The Fiducia MGA Company
Limited
|
35.18
|
31.12.23
|
345,832
|
511,692
|
Specialist UK Marine Cargo
Underwriting Agency
|
|
|
|
|
|
|
LEBC Holdings Limited
|
61.86
|
30.09.23
|
(671,916)
|
(2,427,586)
|
Independent financial advisor
company
|
|
|
|
|
|
|
Lilley Plummer Holdings
Limited
|
30.00
|
31.12.23
|
2,849,170
|
2,559,514
|
Specialist Marine broker
|
|
|
|
|
|
|
Neutral Bay Investments
Limited
|
49.90
|
31.03.23
|
4,054,833
|
218,553
|
Investment holding
company
|
|
|
|
|
|
|
New Denison
Limited4
|
40.00
|
-
|
-
|
-
|
Dormant company
|
|
|
|
|
|
|
Pantheon Specialty
Group Limited5
|
32.00
|
-
|
-
|
-
|
Holding company for specialist
insurance broker
|
|
|
|
|
|
|
Sage Program Underwriters
Inc
|
30.00
|
31.12.23
|
(12,151)
|
48,267
|
Specialist Managing General
Agency
|
|
|
|
|
|
|
Stewart Specialty Risk Underwriting
Limited
|
30.00
|
31.12.23
|
6,013,626
|
3,096,411
|
Specialist Canadian Casualty
Underwriting Agency
|
|
|
|
|
|
|
Verve Risk Services
Limited6
|
35.00
|
-
|
-
|
-
|
Specialist Managing General
Agency
|
|
|
|
|
|
|
XPT Group LLC
|
27.49
|
31.12.23
|
(17,929,386)
|
(6,089,523)
|
USA Specialty lines insurance
distribution company
|
|
|
|
|
|
|
1Recent statutory financial information is not available for
Criterion Underwriting Pte Limited as the company is not currently
trading.
2Dempsey Group Limited is a newly incorporated company.
Statutory accounts are not available as these are not yet
due.
3 Devonshire UW Topco Limited is a
newly incorporated company. Statutory accounts are not available as
these are not yet due.
4New Denison Limited is
a newly incorporated company that is not currently trading.
Statutory accounts are not available as these are not yet
due.
5Pantheon Specialty Group Limited is a newly incorporated
company. Statutory accounts are not available as these are not yet
due.
6Verve Risk Services Limited is a newly incorporated company.
Statutory accounts are not available as these are not yet
due.
The Group's 35% equity investment
in EC3 Brokers Group Limited has not been listed above as the
company went into administration in November 2022 and remained in
administration as at 31st July 2024. The Group does not expect to
recover any amounts in respect of this investment which has been
provided against in full.
The aggregate capital and reserves
and profit/(loss) for the year shown above are extracted from the
relevant local GAAP accounts of the investee companies.
5. CURRENT INVESTMENTS - TREASURY
PORTFOLIO
Group
|
|
Unaudited
|
|
Unaudited
|
|
Audited
|
At
valuation
|
|
31st July
2024
|
|
31st July
2023
|
|
31st January 2024
|
|
|
£'000
|
|
£'000
|
|
£'000
|
|
|
|
|
|
|
|
Market value at 1st
February
|
|
27,525
|
|
11,337
|
|
11,337
|
Additions at cost
|
|
44,750
|
|
1,000
|
|
64,000
|
Disposals
|
|
(16,250)
|
|
(10,006)
|
|
(48,430)
|
Change in value in the
period
|
|
1,125
|
|
89
|
|
618
|
Market value at period end
|
|
£57,150
|
|
£2,420
|
|
£27,525
|
|
|
|
|
|
|
|
Disclosed as:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash
equivalents
|
|
57,150
|
|
2,340
|
|
27,447
|
Investments - treasury
portfolio
|
|
-
|
|
80
|
|
78
|
Total
|
|
£57,150
|
|
£2,420
|
|
£27,525
|
|
|
|
|
|
|
|
Investment fund split:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAM London Limited
|
|
14,566
|
|
12
|
|
7,175
|
Rathbone
Investment Management Limited
|
|
21,183
|
|
2,408
|
|
10,310
|
Rothschild
& Co Wealth Management UK Limited
|
|
21,401
|
|
-
|
|
10,040
|
Total
|
|
£57,150
|
|
£2,420
|
|
£27,525
|
|
|
|
|
|
|
|
The treasury portfolio comprises of
investment funds managed and valued by the Group's investment
managers, GAM London Limited, Rathbone Investment Management
Limited and Rothschild & Co Wealth Management UK Limited.
All investments in securities are included at year end market
value.
The initial investment into the
funds was made following the realisation of the Group's investment
in Summa Insurance Brokerage, S.L. in 2022 and further funds were
invested following the sale of Kentro Capital Limited in the 12
months to 31st January 2024. Further funds have been invested
following the sale of Paladin Holdings Limited during the current
period.
The purpose of the funds is to hold
(and grow) the Group's surplus cash until such time that suitable
investment opportunities arise.
As at 31st July 2024 all amounts
held in the funds were non-risk interest bearing deposits (as at
31st July 2023, of the total £2,419,764 held within the funds, only
£79,992 was risk bearing, with the remaining funds of £2,339,772
being non-risk interest bearing deposits and as at 31st January
2024 of the total £27,525,222 held within the funds, only £78,462
was risk bearing, with the remaining funds of £27,446,760 being
non-risk interest bearing deposits).
The risk bearing fund values can
increase, but also have the potential to fall below the amount
initially invested by the Group. However, the performance of each
fund is monitored on a regular basis and the appropriate action is
taken if there is a prolonged period of poor
performance.
Investment management costs of
£71,491 (6 months to 31st July 2023: £5,667 and 12 months to 31st
January 2024: £15,569) were charged to the Consolidated Statement
of Comprehensive Income during the period.
6. REALISED GAINS / (LOSSES) ON DISPOSAL OF
EQUITY INVESTMENTS
The realised gains / (losses) on
disposal of investments for the period comprises of a net gain of
£1,551,216 (6 months to 31st July 2023: net loss on disposal of
investments of £(40,689) and 12 months to 31st January 2024: net
loss on disposal of investments of £(36,689)).
£1,547,838 of this net gain was in
relation to the Group's disposal of its entire 38.63% holding in
Paladin Holdings Limited ("Paladin") for initial cash consideration
of £42,075,838, compared to the attributable fair value of
£40,528,000 at 1st February 2024.
As outlined in Note 4, the Group
expects to receive deferred contingent consideration based upon
Paladin achieving certain EBITDA growth targets. The total carrying
value of the Group's investment in Paladin as at 1st February 2024
including the deferred contingent consideration was £49,549,000. On
disposal, the fair value attributed to the deferred contingent
consideration element of the sale of £9,021,000 was reclassified
within the Consolidated Statement of Financial Position from
'Investments - assets held for sale' to a debtor balance included
within 'Other receivables'. As at 31st July 2024 the fair value of
the deferred contingent consideration was revalued at £7,668,000
resulting in a loss of £1,353,000 which has been recognised within
the Consolidated Statement of Comprehensive Income under 'Net
(provision) / release of provision made against equity investments
and loans'.
The disposal of Paladin resulted in
a net release of previously unrealised gains to Retained Earnings
from the Fair Value Reserve of £49,545,500.
£3,378 of this net gain was in
relation to the receipt of an additional capital distribution from
the Group's former investment in Walsingham Holdings Limited
("WHL") following the conclusion of WHL's liquidation process which
commenced in February 2022.
The amount included in realised
gains / (losses) on disposal of investments for the 6 months to
31st July 2023 comprised of a net loss of £(40,689).
£132,000 of this net loss was in
respect of the Group's disposal of its entire 40% equity investment
in Denison and Partners Limited ("Denison and Partners") for nil
cash consideration, compared to the fair value of £132,000 at 1st
February 2023. There were no releases of previously unrealised
gains or losses to Retained Earnings from the Fair Value Reserve as
a result of this disposal in that period as the investment had been
held at cost.
The above realised loss arising
from the disposal of Denison and Partners was offset by a realised
gain of £91,311 relating to an additional capital distribution
recognised during that period from the Group's former investment in
Summa Insurance Brokerage, S.L. ("Summa") which was sold during the
year to 31st January 2022.
The amount included in realised
gains / (losses) on disposal of investments for the 12 months to
31st January 2024 comprised of a net loss of £(36,689).
This comprised of the £(40,689) net
realised loss in relation to Denison and Partners and Summa
referred to above, offset by a £4,000 realised gain relating to the
Group's partial disposal of 250,000 ordinary shares (c.5.9% at the
time of divestment) in Paladin in that year which were held under a
call option arrangement, for consideration of £804,000, compared to
the fair value of £800,000 at 1st February 2023. There were no
releases of previously unrealised gains or losses to Retained
Earnings from the Fair Value Reserve as a result of this disposal
in that year as the investment had been held at cost.
7. RECONCILIATION
OF MOVEMENTS IN
SHAREHOLDERS' FUNDS
|
|
|
|
|
|
|
|
|
|
|
Share
|
|
Reverse
|
Capital
|
Capital
|
|
|
|
Share
|
premium
|
Fair
value
|
acquisition
|
redemption
|
contribution
|
Retained
|
|
|
capital
|
account
|
reserve
|
reserve
|
reserve
|
reserve
|
earnings
|
Total
|
|
(£'000)
|
(£'000)
|
(£'000)
|
(£'000)
|
(£'000)
|
(£'000)
|
(£'000)
|
(£'000)
|
|
|
|
|
|
|
|
|
|
At 1st February
2024
|
3,729
|
29,345
|
112,768
|
393
|
25
|
72
|
82,839
|
229,171
|
|
|
|
|
|
|
|
|
|
Comprehensive income for the
period
|
-
|
-
|
25,719
|
-
|
-
|
-
|
901
|
26,620
|
|
|
|
|
|
|
|
|
|
Net transfers on disposal of
investments (Note 4 & Note 6)
|
-
|
-
|
(49,546)
|
|
|
|
49,546
|
-
|
|
|
|
|
|
|
|
|
|
Dividends paid
|
-
|
-
|
-
|
-
|
-
|
-
|
(3,964)
|
(3,964)
|
|
|
|
|
|
|
|
|
|
Repurchase of Company shares (Note
3)
|
-
|
-
|
-
|
-
|
-
|
-
|
(327)
|
(327)
|
|
|
|
|
|
|
|
|
|
Share based payment
arrangements
(Note 10)
|
-
|
6
|
-
|
-
|
-
|
-
|
210
|
216
|
|
|
|
|
|
|
|
|
|
Amounts received from the Employee
Benefit Trust on the sale of shares held under joint ownership
(Note 10)
|
-
|
-
|
-
|
-
|
-
|
-
|
1,157
|
1,157
|
|
|
|
|
|
|
|
|
|
At 31st July
2024
|
£3,729
|
£29,351
|
£88,941
|
£393
|
£25
|
£72
|
£130,362
|
£252,873
|
|
|
|
|
|
|
|
|
|
8. LOAN AND EQUITY COMMITMENTS
On 26th June 2020 (as amended on
1st June 2023) the Group entered into an agreement to provide Sage
Program Underwriters, Inc. with a loan facility of USD 300,000. As
at 31st July 2024 USD 150,000 had been drawn down, leaving a
remaining undrawn facility of USD 150,000. Any drawdown is subject
to satisfying certain agreed criteria.
On 28th April 2023 the Group
entered into an agreement to provide Verve Risk Services Limited
with a loan facility of £569,209. As at 31st July 2024 the full
£569,209 had been drawn down. Since 31st July 2024 this facility
has been increased by a further £500,000 to £1,069,209 and a
further £75,000 has been drawn down, increasing total loans
outstanding to £644,209, with a remaining undrawn facility of
£425,000 at the date of this report.
On 21st December 2023 the Group
entered into an agreement to provide Dempsey Group Limited with a
loan facility of £1,570,000. As at 31st July 2024 £875,000 had been
drawn down, leaving a remaining undrawn facility of £695,000. Since
31st July 2024 a further £250,000 has been drawn down from this
facility increasing total loans outstanding to £1,125,000, with a
remaining undrawn facility of £445,000 at the date of this
report.
On 27th March 2024 the Group
entered into an agreement to provide Devonshire UW Topco Limited
with a loan facility of £1,600,000. As at 31st July 2024 £990,125
had been drawn down, leaving a remaining undrawn facility of
£609,875. Since 31st July 2024 a further £300,000 has been drawn
down from this facility increasing total loans outstanding to
£1,290,125, with a remaining undrawn facility of £309,875 at the
date of this report.
9. DEFERRED TAX AND CONTINGENT
LIABILITIES
Group
|
|
Unaudited
|
|
Unaudited
|
|
Audited
|
|
|
31st July
2024
|
|
31st July
2023
|
|
31st January 2024
|
|
|
£'000
|
|
£'000
|
|
£'000
|
|
|
|
|
|
|
|
At 1st February
|
|
6,687
|
|
5,631
|
|
5,631
|
Tax movement relating to investment
revaluation for the period
|
|
2,394
|
|
(27)
|
|
1,056
|
|
|
|
|
|
|
|
At
period end
|
|
£9,081
|
|
£5,604
|
|
£6,687
|
Finance (No.2) Act 2017 introduced
significant changes to the Substantial Shareholding Exemption
("SSE") rules in Taxation of Chargeable Gains Act 1992 Sch. 7AC
which applied to share disposals on or after 1 April 2017. In
general terms, the rule changes relaxed the conditions for the
Group to qualify for SSE on a share disposal.
New tax legislation was introduced
in the US in 2018 which taxes at source gains on disposal of any
foreign partnership interests in US limited liability companies
("LLCs"). As such, deferred tax needs to be assessed on any
potential net gains from the Group's investment interests in US
LLCs.
Having reviewed the Group's current
investment portfolio, the directors consider that the Group should
benefit from this reform to the SSE rules on all non-US LLC
investments. As a result, the directors anticipate that on a
disposal of shares in the Group's current non-US LLC investments,
so long as the shares have been held for 12 months they should
qualify for SSE and no tax charge should arise on their
disposal.
The requirement for a deferred tax
provision is subject to continual assessment of each investment to
test whether the SSE conditions continue to be met based upon
information that is available to the Group and that there is no
change to the accounting treatment in this regard under UK-adopted
international accounting standards. It should also be noted that,
until the date of the actual disposal, it will not be possible to
ascertain if all the SSE conditions are likely to have been met
and, moreover, obtaining agreement of the tax position with HM
Revenue & Customs may possibly not be forthcoming until several
years after the end of a period of accounts.
Having assessed the current US
portfolio, the directors anticipate that there is a requirement to
provide for deferred tax in respect of the unrealised gains on
investments under the current requirements of UK-adopted
international accounting standards as the US LLC investments
currently show a net gain. As such, a provision of £9,081,000 has
been made as at 31st July 2024 (Interim 6 months to 31st July 2023:
£5,604,000 and full year to 31st January 2024:
£6,687,000).
The deferred tax provision of
£9,081,000 as at 31st July 2024 has been calculated based upon an
assessment of the US tax liability arising from the valuations of
the Group's holdings within US LLCs at 31st July 2024, using the US
Federal rate of 21% together with US State Tax rates prevailing in
the states where the Group's US LLCs operate, which range between
0% and 11.5%. Adjustments were then made based upon available
allowances and taxable losses. Given the complexity, the Group
utilised the services of a specialist US tax advisory
firm.
The UK corporation tax increased
from 19% to 25% effective 1st April 2023. This change in tax rate
has not had a material impact on the Group financial statements for
the period ended 31st July 2024 and is not expected to have a
material impact on future periods as the directors do not consider
there is any deferred tax due at the year end in respect of its
non-US LLC investments due to the SSE rules.
10.
SHARE BASED PAYMENT
ARRANGEMENTS
Joint Share Ownership Plan
During the year to 31st January
2019, B.P. Marsh & Partners Plc entered into joint share
ownership agreements ("JSOAs") with certain employees and
directors.
On 12th June 2018 1,461,302 new 10p
Ordinary shares in the Company were issued and transferred into
joint beneficial ownership for 12 employees (including 4 directors)
under the terms of joint share ownership agreements. No
consideration was paid by the employees for their interests in the
jointly-owned shares.
The new Ordinary shares have been
issued into the name of RBC cees Trustee Limited ("the Trustee") as
trustee of the B.P. Marsh Employees' Share Trust ("the Employee
Benefit Trust") at a subscription price of 281 pence per share,
being the mid-market closing price on 12th June 2018. Following the
acquisition of the Trustee by JTC Plc on 10th December 2020, the
Trustee has since been rebranded to JTC Employer Solutions Trustee
Limited.
The jointly-owned shares are
beneficially owned by (i) each of the 7 currently participating
employees and (ii) the trustee of the Employee Benefit Trust upon
and subject to the terms of the JSOAs entered into between the
participating employee, the Company and the Trustee.
Under the terms of the JSOAs, the
employees and directors are entitled to receive on vesting the
growth in value of the shares above a threshold price of 281 pence
per share (market value at the date of grant) plus an annual
carrying charge of 3.75% per annum (simple interest) to the market
value at the date of grant to the date of vesting. The Employee
Benefit Trust retains the carrying cost, with 281 pence per share
due back to the Company.
On 12th June 2021 (the "vesting
date") the performance criteria were met, after which the members
of the scheme became joint beneficial owners of the shares and
therefore became entitled to any gain on sale of the shares in
excess of 312.6 pence per share. Alternatively, the participant and
the Trustee may exchange their respective interests in the
jointly-owned shares such that each becomes the sole owner of a
number of Ordinary shares of equal value to their joint
interests.
There were 254,414 shares where the
performance criteria was not met on the vesting date that had been
forfeited by departing employees and which remained unallocated
within the Employee Benefit Trust as at 31st January
2022.
During the year to 31st January
2023, 18,155 of the 254,414 unallocated shares within the Employee
Benefit Trust were transferred to the B.P. Marsh SIP Trust ("SIP
Trust") to be used as part of the 22-23 SIP awards made in April
2022. Following this transfer and as at 31st January 2024 there
were 1,443,147 shares held within the Employee Benefit Trust, of
which there were 236,259 shares where the performance criteria was
not met on the vesting date and which remained unallocated. The
Employee Benefit Trust remains the owner of these unallocated
shares and they do not have dividend and voting rights
attached.
On 26th October 2023 following the
removal of a dividend waiver and block on voting rights on the
1,206,888 allocated ordinary shares held by the Employee Benefit
Trust, these ordinary shares became eligible for dividend and
voting rights and therefore became fully dilutive for the
Group.
Provided that the shares are
eventually sold from the Employee Benefit Trust for at least 284.5
pence per share on average, the Group would be entitled to receive
£4,106,259 in total.
During the period 404,448 of the
shares held within the Employee Benefit Trust were sold, including
99,700 shares jointly-owned by 2 executive directors of the
Company. As at 31st July 2024 1,038,699 shares remained within the
Employee Benefit Trust, of which 236,259 were
unallocated.
Of the £4,106,259 receivable by the
Group in total, £1,157,000 was received during the period, leaving
a balance outstanding of £2,949,259. Since 31st July 2024 a further
£143,259 has been received leaving a balance outstanding of
£2,806,000. As such, provided that the remaining shares are
eventually sold from the Employee Benefit Trust for at least
270.1p/share on average, the Group will receive this balance in
full.
Share Incentive
Plan
During the year to 31st January
2017 the Group established an HMRC approved Share Incentive Plan
("SIP").
During the period a total of 22,380
ordinary shares in the Company, which were held in Treasury as at
31st January 2024 (6 months to 31st July 2023 and also 12 months to
31st January 2024, 32,780 ordinary shares in the Company, of which
4,850 were held in Treasury as at 31st January 2023 and 27,930 were
bought back into Treasury during that period/year), were
transferred to the B.P. Marsh SIP Trust ("SIP Trust"). As a result,
a total of 22,380 ordinary shares in the Company were available for
allocation to the participants of the SIP (6 months to 31st July
2023 and also 12 months to 31st January 2024: 32,780 ordinary
shares were available for allocation).
On 11th April 2024, a total of 12
eligible employees (including 3 executive directors of the Company)
applied for the 24-25 SIP and were each granted 746 ordinary shares
("24-25 Free Shares"), representing approximately £3,600 at the
price of issue.
Additionally, on the same date, all
eligible employees were also invited to take up the opportunity to
acquire up to £1,800 worth of ordinary shares ("Partnership
Shares"). For every Partnership Share that an employee acquired,
the SIP Trust offered two ordinary shares in the Company ("Matching
Shares") up to a total of £3,600 worth of shares. All 12 eligible
employees (including 3 executive directors of the Company) took up
the offer and acquired the full £1,800 worth of Partnership Shares
(373 ordinary shares) and were therefore awarded 746 Matching
Shares.
The 24-25 Free and Matching Shares
are subject to a 1 year forfeiture period.
A total of 22,380 (6 months to 31st
July 2023 and also 12 months to 31st January 2024: 32,780) Free,
Matching and Partnership Shares were granted to the 12 (6 months to
31st July 2023 and also 12 months to 31st January 2024: 11)
eligible employees during the period, including 5,595 (6 months to
31st July 2023 and also 12 months to 31st January 2024: 8,940)
granted to 3 (6 months to 31st July 2023 and also 12 months to 31st
January 2024: 3) executive directors of the Company.
20,102 ordinary shares were
withdrawn from the SIP Trust during the period (6 months to 31st
July 2023 and 12 months to 31st January 2024: No
withdrawals).
As at 31st July 2024, and after
adjusting for a total of 40,053 ordinary shares withdrawn from the
SIP Trust by employees on departure and 8,334 ordinary shares
forfeited on departure (since inception), a total of 296,395 Free,
Matching and Partnership Shares had been granted to 11 currently
eligible employees under the SIP, including 101,787 granted to 3
executive directors of the Company.
£42,772 of the IFRS 2 charges (6
months to 31st July 2023: £38,427 and 12 months to 31st January
2024: £77,492) associated with the award of the SIP shares to the
12 (6 months to 31st July 2023 and also 12 months to 31st January
2024: 11) eligible directors and employees of the Company have been
recognised in the Statement of Comprehensive Income as employment
expenses.
The results of the SIP Trust have
been fully consolidated within these financial statements on the
basis that the SIP Trust is controlled by the Company.
Share Option
Plan
On 6th September 2023 the Group
established a new employee Share Option Plan ("SOP").
On 17th October 2023 Share Options
("Options") over 1,682,500 ordinary shares of 10p each in the
Company, in aggregate, were granted to 12 employees, including 3
executive directors of the Company.
The total number of Options
available for allocation amounted to 1,685,970, which represented
4.5% of the Company's total ordinary shares in issue at the time
the SOP was adopted. 3,470 Options remain unallocated as at 31st
July 2024.
Each of the Options will vest, on a
ratchet basis, subject to certain Net Asset Value growth targets
being achieved for the three consecutive financial years ending
31st January 2024, 31st January 2025 and 31st January 2026
("Performance Period"). The first exercise date is 6th September
2026 whereby 50% of vested Options will be exercisable at 10p per
share, with the remaining 50% exercisable at 10p per share from 6th
September 2027.
The number of Options which vest
will vary depending on the level of Net Asset Value growth
achieved, subject to the growth performance criteria as set out
below, alongside the percentage of Options that will vest at each
value:
Compounded annual growth of Net Asset Value over the
Performance Period
|
%
vesting of Options
|
Less than 8.5%
|
0%
|
Between 8.5% and less than
9.25%
|
25%
|
Between 9.25% and less than
10%
|
50%
|
10% or above
|
100%
|
For these purposes, Net Asset Value
is defined as "audited Total Assets less Total Liabilities for the
consolidated Group plus any dividends or other form of shareholder
return that are paid in the relevant Financial Year".
Therefore, for all Options to vest,
the Net Asset Value (as defined above) would need to exceed
£252.2m, adjusted for any shareholder distributions.
The details of the arrangements are
described in the following table:
Nature of the
arrangement
|
Share options
|
Form of option
|
Asian options
|
Type of option
|
Nominal-cost option
|
Date of grant
|
17th October 2023
|
Number of instruments
granted
|
1,682,500
|
Exercise price (pence)
|
10.00
|
Share price (market value) at grant
(pence)
|
354.22
|
Vesting period (years)
|
3 years
|
Vesting conditions
|
The recipient must remain an
employee throughout the vesting period. The awards vest after 3
years or earlier resulting from either:
a) a change of control
resulting from a person, or another company, obtaining control of
the Company either (i) as a result of a making a General Offer;
(ii) pursuant to a court sanctioned Compromise or Scheme of
Arrangement; or (iii) in consequence of a Compulsory Acquisition;
or
b) a person or another
company becoming bound or entitled to acquire shares in the Company
pursuant to sections 974 to 991 of the Companies Act 2006;
or
c) a winding
up.
In such
circumstances, an Option may be exercised at any time during the
period of six months following the date of the event. Any Option
not exercised within this period shall lapse immediately upon the
expiry of the six-month period.
If a
Participant ceases to be a Group Employee before the Vesting Date
by reason of being a Good Leaver, the Pro-rated Portion of their
Option shall be capable of vesting on the Cessation
Date.
If a
Participant ceases to be a Group Employee by reason of being a Good
Leaver after the Vesting Date but before the Exercise Date the
Participant shall be entitled to exercise the vested Shares of such
a vested Option at any time after the Exercise Date.
|
Performance period
|
The three consecutive financial
years beginning 1st February 2023 (i.e. the three periods ending on
31st January 2026)
|
Net Asset Value at which Options
vest
|
10% compound annual growth over the
Performance Period, or a Net Asset Value threshold of £252.2m,
adjusted for any shareholder distributions, with the percentage of
Options vesting as follows:
Compound Annual Growth
achieved:
Less than 8.5%: 0% vest
Between 8.5% and less than 9.25%:
25% vest
Between 9.25% and less than 10%:
50% vest
10% or above: 100% vest
|
Exercise period
|
50% of the vested options may be
exercised immediately after the end of the Performance Period or
6th September 2026 (whichever is the latter) with the remaining 50%
being capable of exercise after 6th September 2027
|
Expected volatility
|
19% annual volatility
|
Risk free rate
|
5%
|
Expected annual dividends
(pence)
|
2.78
|
Settlement
|
Cash settled on sale of
shares
|
% expected to vest (based upon
leavers)
|
80%
|
Number expected to vest
|
1,346,000
|
Valuation model
|
Monte Carlo techniques using the
assumptions of Geometric Brownian Motion
|
Fair value per granted instrument
(pence)
|
75.24
|
Charge for period ended 31st July
2024
|
£152,126
|
£152,126 of the IFRS 2 charges (6
months to 31st July 2023: N/A and 12 months to 31st January 2024:
£89,437) associated with the grant of the SOP options to 12 (2023:
N/A) eligible directors and employees of the Company has been
recognised in the Statement of Comprehensive Income as employment
expenses.
-Ends-